634(top 0.1%)
PR articles
54.0K(top 0.1%)
PR citations
110(top 0.1%)
PR h-index
118(top 0.1%)
h-index
654
documents
65.6K
doc citations
6.0K
citing journals
100
times ranked

Publications

640 peer-reviewed articles • 57,101 peer-reviewed citations • Sorted by year • Download PDF (PDF by citations)
Sort: Year | Citations
#ArticleIFCitationsLinks
1Exploring the contribution of genetic variants to high sunitinib exposure in patients with cancer2.55Citations (PDF)
2Risk of progression in patients with primary T1 high grade non-muscle invasive bladder cancer – a contemporary cohort
European Urology Oncology, 2025, 8, 249-252
5.82Citations (PDF)
3Smoking behavior and the risks of tumor recurrence and progression in patients with non‐muscle‐invasive bladder cancer
International Journal of Cancer, 2025, 156, 1529-1540
4.33Citations (PDF)
4The impact of positive surgical margins after cystectomy on oncological outcomes: a nationwide study
BJU International, 2025, 135, 766-774
3.22Citations (PDF)
5Pre- and post-diagnosis body weight trajectories in patients with localized renal cell cancer
Cancer Causes and Control, 2025, 36, 497-507
1.71Citations (PDF)
6Fluid intake and recurrence and progression risk of patients with non‐muscle‐invasive bladder cancer
BJU International, 2025, 136, 429-438
3.20Citations (PDF)
7Multiparametric MRI for local staging in patients with suspected muscle-invasive bladder cancer: study protocol for a multicentre, non-inferiority randomised controlled trial (the BladParadigm study)
BMJ Open, 2025, 15, e100002
1.94Citations (PDF)
8Health-related Quality of Life During the First 4 Years After Non–Muscle-invasive Bladder Cancer Diagnosis: Results of a Large Multicentre Prospective Cohort
European Urology Oncology, 2024, 7, 829-837
5.88Citations (PDF)
9CYP2A6 Activity and Cigarette Consumption Interact in Smoking-Related Lung Cancer Susceptibility
Cancer Research, 2024, 84, 616-625
3.817Citations (PDF)
10Treatment Patterns and Use of Immune Checkpoint Inhibitors Among Patients with Metastatic Bladder Cancer in a Dutch Nationwide Cohort0.62Citations (PDF)
11Lung Cancer in Ever- and Never-Smokers: Findings from Multi-Population GWAS Studies1.110Citations (PDF)
12Multi-trait analysis characterizes the genetics of thyroid function and identifies causal associations with clinical implications13.715Citations (PDF)
13Multi-trait analysis characterizes the genetics of thyroid function and identifies causal associations with clinical implications13.752Citations (PDF)
14Real-world oncological outcomes of a nationwide, prospective bladder cancer cohort
European Urology, 2024, 85, S1354
2.10Citations (PDF)
15Hereditary and Familial Traits in Urological Cancers and Their Underlying Genes0.66Citations (PDF)
16Associations of physical activity and sedentary time with health-related quality of life in patients with localized renal cell cancer: a cross-sectional analysis within the ReLife study2.20Citations (PDF)
17Longitudinal associations of adherence to lifestyle recommendations and health‐related quality of life in patients with non‐muscle invasive bladder cancer
International Journal of Cancer, 2023, 152, 2032-2042
4.39Citations (PDF)
18Adherence to lifestyle recommendations after non-muscle invasive bladder cancer diagnosis and risk of recurrence4.721Citations (PDF)
19Minimum Volume Standards: An Incentive To Perform More Radical Cystectomies?0.60Citations (PDF)
20Chemoradiation for muscle-invasive bladder cancer using 5-fluorouracil versus capecitabine: A nationwide cohort study
Radiotherapy and Oncology, 2023, 183, 109584
2.013Citations (PDF)
21The accuracy of cystoscopy in predicting detrusor invasion in newly diagnosed bladder cancer patients
European Urology, 2023, 83, S1524-S1525
2.10Citations (PDF)
22Editorial Concerning “The Association Between Diabetes Medication Use and Tumour Characteristics at Diagnosis in Patients with Urothelial Carcinoma: A Retrospective Registry-Based Study”
Bladder Cancer, 2023, 9, 83-85
0.50Citations (PDF)
23Global trends in the epidemiology of bladder cancer: challenges for public health and clinical practice70.7322Citations (PDF)
24Cohort profile – the Renal cell cancer: Lifestyle, prognosis and quality of life (ReLife) study in the Netherlands
BMJ Open, 2023, 13, e066909
1.93Citations (PDF)
25The accuracy of cystoscopy in predicting muscle invasion in newly diagnosed bladder cancer patients
World Journal of Urology, 2023, 41, 1829-1835
2.220Citations (PDF)
26Changes to Primary End Points in Randomized Clinical Trials on Immune Checkpoint Inhibitors in Urothelial, Renal Cell, and Lung Cancers
JAMA Oncology, 2023, 9, 1144
14.32Citations (PDF)
27Genetic insights into resting heart rate and its role in cardiovascular disease13.733Citations (PDF)
28Body mass index and waist circumference in relation to risk of recurrence and progression after non‐muscle invasive bladder cancer
Cancer Medicine, 2023, 12, 20459-20469
2.69Citations (PDF)
29Genetic relationship between the immune system and autism2.417Citations (PDF)
30No Association Between BCG Instillations and COVID-19 Incidence in a Dutch Non-Muscle Invasive Bladder Cancer Cohort
Bladder Cancer, 2023, 9, 355-363
0.50Citations (PDF)
31Potential role for immune-related genes in autism spectrum disorders: Evidence from genome-wide association meta-analysis of autistic traits
Autism, 2022, 26, 361-372
5.230Citations (PDF)
32Overall Survival of Patients Receiving Cisplatin or Carboplatin for Primary Metastatic Urothelial Carcinoma of the Bladder: A Contemporary Dutch Nationwide Cohort Study
European Urology Focus, 2022, 8, 995-1002
3.515Citations (PDF)
33Skeletal muscle radiodensity and visceral adipose tissue index are associated with survival in renal cell cancer – A multicenter population-based cohort study
Clinical Nutrition, 2022, 41, 131-143
5.329Citations (PDF)
34Polygenic risk modeling for prediction of epithelial ovarian cancer risk3.061Citations (PDF)
35Non‐metastatic muscle‐invasive bladder cancer: the role of age in receiving treatment with curative intent
BJU International, 2022, 130, 764-775
3.26Citations (PDF)
36Genome-wide interaction analysis identified low-frequency variants with sex disparity in lung cancer risk
Human Molecular Genetics, 2022, 31, 2831-2843
2.97Citations (PDF)
37Gene–gene interaction of AhRwith and within the Wntcascade affects susceptibility to lung cancer3.03Citations (PDF)
38Iam hiQ—a novel pair of accuracy indices for imputed genotypes
BMC Bioinformatics, 2022, 23,
3.04Citations (PDF)
39Limited Changes in Lifestyle Behaviours after Non-Muscle Invasive Bladder Cancer Diagnosis
Cancers, 2022, 14, 960
3.810Citations (PDF)
40Impact of the COVID-19 outbreak on prostate cancer care in the Netherlands1.717Citations (PDF)
41The Impact of the COVID-19 Pandemic on Bladder Cancer Care in the Netherlands
Bladder Cancer, 2022, 8, 139-154
0.56Citations (PDF)
42Evidence or Prejudice? Critical Re-Analysis of Randomized Controlled Trials Comparing Overall Survival After Cisplatin Versus Carboplatin-Based Regimens in Advanced Urothelial Carcinoma
Clinical Genitourinary Cancer, 2022, 20, e346-e352
2.35Citations (PDF)
43A Large-Scale Genome-Wide Gene-Gene Interaction Study of Lung Cancer Susceptibility in Europeans With a Trans-Ethnic Validation in Asians
Journal of Thoracic Oncology, 2022, 17, 974-990
2.137Citations (PDF)
44Adherence to the WCRF/AICR Cancer Prevention Recommendations and Risk of Recurrence in Non-muscle Invasive Bladder Cancer0.20Citations (PDF)
45Association Study between Polymorphisms in DNA Methylation–Related Genes and Testicular Germ Cell Tumor Risk1.111Citations (PDF)
46Role of multidisciplinary team meetings in implementation of chemohormonal therapy in metastatic prostate cancer in daily practice4.06Citations (PDF)
47Cross-ancestry genome-wide meta-analysis of 61,047 cases and 947,237 controls identifies new susceptibility loci contributing to lung cancer
Nature Genetics, 2022, 54, 1167-1177
25.2113Citations (PDF)
48Genome-wide association analyses of physical activity and sedentary behavior provide insights into underlying mechanisms and roles in disease prevention
Nature Genetics, 2022, 54, 1332-1344
25.2222Citations (PDF)
49Validation and reliability of the Dutch version of the EORTC QLQ-BLM30 module for assessing the health-related quality of life of patients with muscle invasive bladder cancer2.97Citations (PDF)
50Association between a 46-SNP Polygenic Risk Score and melanoma risk in Dutch patients with familial melanoma
Journal of Medical Genetics, 2021, 58, 760-766
3.813Citations (PDF)
51Integration of multiomic annotation data to prioritize and characterize inflammation and immune‐related risk variants in squamous cell lung cancer
Genetic Epidemiology, 2021, 45, 99-114
3.17Citations (PDF)
52Causal relationships between body mass index, smoking and lung cancer: Univariable and multivariable Mendelian randomization
International Journal of Cancer, 2021, 148, 1077-1086
4.3151Citations (PDF)
53Variation in the Prescription of Androgen Deprivation Therapy in Intermediate- and High-risk Prostate Cancer Patients Treated with Radiotherapy in the Netherlands, and Adherence to European Association of Urology Guidelines: A Population-based Study
European Urology Focus, 2021, 7, 332-339
3.58Citations (PDF)
54Assessing Lung Cancer Absolute Risk Trajectory Based on a Polygenic Risk Model
Cancer Research, 2021, 81, 1607-1615
3.885Citations (PDF)
55Hospital volume is associated with postoperative mortality after radical cystectomy for treatment of bladder cancer
BJU International, 2021, 128, 511-518
3.213Citations (PDF)
56Genome-wide association meta-analysis identifies pleiotropic risk loci for aerodigestive squamous cell cancers
PLoS Genetics, 2021, 17, e1009254
3.236Citations (PDF)
57Low Risk of Severe Complications After a Single, Post-Operative Instillation of Intravesical Chemotherapy in Patients with TaG1G2 Urothelial Bladder Carcinoma
Bladder Cancer, 2021, 7, 193-203
0.51Citations (PDF)
58Pleiotropy-guided transcriptome imputation from normal and tumor tissues identifies candidate susceptibility genes for breast and ovarian cancer1.610Citations (PDF)
59Identification of 22 susceptibility loci associated with testicular germ cell tumors13.767Citations (PDF)
60Validation and reliability of the Dutch version of the EORTC QLQ-NMIBC24 Questionnaire Module for patients with non-muscle-invasive bladder cancer2.67Citations (PDF)
61Transcriptome‐wide association study reveals candidate causal genes for lung cancer
International Journal of Cancer, 2020, 146, 1862-1878
4.362Citations (PDF)
62Genome‐wide association study of INDELs identified four novel susceptibility loci associated with lung cancer risk
International Journal of Cancer, 2020, 146, 2855-2864
4.318Citations (PDF)
63Immune-mediated genetic pathways resulting in pulmonary function impairment increase lung cancer susceptibility13.739Citations (PDF)
64Hospital-specific probability of cystectomy affects survival from muscle-invasive bladder cancer1.83Citations (PDF)
65GWAS of thyroid stimulating hormone highlights pleiotropic effects and inverse association with thyroid cancer13.7127Citations (PDF)
66Histopathological re-evaluations of biopsies in prostate cancer: a nationwide observational study1.25Citations (PDF)
67Disparities in cancer‐related healthcare among people with intellectual disabilities: A population‐based cohort study with health insurance claims data
Cancer Medicine, 2020, 9, 6888-6895
2.645Citations (PDF)
68Utilization of systemic treatment for metastatic bladder cancer in everyday practice: Results of a nation-wide population-based cohort study1.722Citations (PDF)
69Menstrual Factors, Reproductive History, Hormone Use, and Urothelial Carcinoma Risk: A Prospective Study in the EPIC Cohort1.14Citations (PDF)
70No clear associations of adult BMI and diabetes mellitus with non-muscle invasive bladder cancer recurrence and progression
PLoS ONE, 2020, 15, e0229384
2.322Citations (PDF)
71The genetic architecture of membranous nephropathy and its potential to improve non-invasive diagnosis13.7199Citations (PDF)
72Assessing thyroid cancer risk using polygenic risk scores7.556Citations (PDF)
73Association Analysis of Driver Gene–Related Genetic Variants Identified Novel Lung Cancer Susceptibility Loci with 20,871 Lung Cancer Cases and 15,971 Controls1.18Citations (PDF)
74Comprehensive functional annotation of susceptibility variants identifies genetic heterogeneity between lung adenocarcinoma and squamous cell carcinoma
Frontiers of Medicine, 2020, 15, 275-291
3.033Citations (PDF)
75Survival after radical cystectomy: Progressive versus De novo muscle invasive bladder cancer1.717Citations (PDF)
76Genetic Data from Nearly 63,000 Women of European Descent Predicts DNA Methylation Biomarkers and Epithelial Ovarian Cancer Risk
Cancer Research, 2019, 79, 505-517
3.858Citations (PDF)
77Lung Cancer Risk in Never-Smokers of European Descent is Associated With Genetic Variation in the 5p15.33 TERT-CLPTM1Ll Region
Journal of Thoracic Oncology, 2019, 14, 1360-1369
2.137Citations (PDF)
78Bladder cancer survival: Women only fare worse in the first two years after diagnosis1.817Citations (PDF)
79Interim Results from the IMPACT Study: Evidence for Prostate-specific Antigen Screening in BRCA2 Mutation Carriers
European Urology, 2019, 76, 831-842
2.1227Citations (PDF)
80Shared heritability and functional enrichment across six solid cancers13.7108Citations (PDF)
81One‐carbon metabolism biomarkers and risk of urothelial cell carcinoma in the European prospective investigation into cancer and nutrition
International Journal of Cancer, 2019, 145, 2349-2359
4.37Citations (PDF)
82Elevated Platelet Count Appears to Be Causally Associated with Increased Risk of Lung Cancer: A Mendelian Randomization Analysis1.127Citations (PDF)
83A Potential Role for the STXBP5-AS1 Gene in Adult ADHD Symptoms
Behavior Genetics, 2019, 49, 270-285
1.36Citations (PDF)
84Exome chip association study excluded the involvement of rare coding variants with large effect sizes in the etiology of anorectal malformations
PLoS ONE, 2019, 14, e0217477
2.35Citations (PDF)
85Low awareness, adherence, and practice but positive attitudes regarding lifestyle recommendations among non–muscle-invasive bladder cancer patients1.88Citations (PDF)
86Evaluation of vitamin D biosynthesis and pathway target genes reveals UGT2A1/2 and EGFR polymorphisms associated with epithelial ovarian cancer in African American Women
Cancer Medicine, 2019, 8, 2503-2513
2.68Citations (PDF)
87The UroLife study: protocol for a Dutch prospective cohort on lifestyle habits in relation to non-muscle-invasive bladder cancer prognosis and health-related quality of life
BMJ Open, 2019, 9, e030396
1.921Citations (PDF)
88Genome-wide Association Study for Tumour Stage, Grade, Size, and Age at Diagnosis of Non–muscle-invasive Bladder Cancer
European Urology Oncology, 2019, 2, 381-389
5.818Citations (PDF)
89Systematic analyses of regulatory variants in DNase I hypersensitive sites identified two novel lung cancer susceptibility loci
Carcinogenesis, 2019, 40, 432-440
2.87Citations (PDF)
90Mendelian Randomization and mediation analysis of leukocyte telomere length and risk of lung and head and neck cancers4.957Citations (PDF)
91The global burden of urinary bladder cancer: an update
World Journal of Urology, 2019, 38, 1895-1904
2.2785Citations (PDF)
92Body Mass Index, Diet-Related Factors, and Bladder Cancer Prognosis: A Systematic Review and Meta-Analysis
Bladder Cancer, 2018, 4, 91-112
0.537Citations (PDF)
93Adult height is associated with increased risk of ovarian cancer: a Mendelian randomisation study
British Journal of Cancer, 2018, 118, 1123-1129
5.518Citations (PDF)
94Genome-wide interaction study of smoking behavior and non-small cell lung cancer risk in Caucasian population
Carcinogenesis, 2018, 39, 336-346
2.833Citations (PDF)
95Prostate-specific antigen velocity in a prospective prostate cancer screening study of men with genetic predisposition
British Journal of Cancer, 2018, 118, 266-276
5.518Citations (PDF)
96Assessment of moderate coffee consumption and risk of epithelial ovarian cancer: a Mendelian randomization study4.918Citations (PDF)
97Body Composition in Relation to Clinical Outcomes in Renal Cell Cancer: A Systematic Review and Meta-analysis
European Urology Focus, 2018, 4, 420-434
3.560Citations (PDF)
98Robust Tests for Additive Gene-Environment Interaction in Case-Control Studies Using Gene-Environment Independence3.39Citations (PDF)
99Dietary patterns and risk of recurrence and progression in non‐muscle‐invasive bladder cancer
International Journal of Cancer, 2018, 142, 1797-1804
4.326Citations (PDF)
100A 3′ untranslated region polymorphism rs2304277 in the DNA repair pathway gene OGG1 is a novel risk modulator for urothelial bladder carcinoma
Annals of Human Genetics, 2018, 82, 74-87
1.16Citations (PDF)
101Fine mapping of MHC region in lung cancer highlights independent susceptibility loci by ethnicity13.755Citations (PDF)
102Epidemiology of Bladder Cancer: A Systematic Review and Contemporary Update of Risk Factors in 2018
European Urology, 2018, 74, 784-795
2.1716Citations (PDF)
103Genome-wide analyses identify a role for SLC17A4 and AADAT in thyroid hormone regulation13.7266Citations (PDF)
104Association of a rare variant of the TNFSF13B gene with susceptibility to Rheumatoid Arthritis and Systemic Lupus Erythematosus3.428Citations (PDF)
105LINC00857 expression predicts and mediates the response to platinum‐based chemotherapy in muscle‐invasive bladder cancer
Cancer Medicine, 2018, 7, 3342-3350
2.636Citations (PDF)
106Exploring the role of low-frequency and rare exonic variants in alcohol and tobacco use
Drug and Alcohol Dependence, 2018, 188, 94-101
2.917Citations (PDF)
107Pre‐diagnostic circulating insulin‐like growth factor‐I and bladder cancer risk in the European Prospective Investigation into Cancer and Nutrition
International Journal of Cancer, 2018, 143, 2351-2358
4.319Citations (PDF)
108Identification of an enhancer region within the TP63/LEPREL1 locus containing genetic variants associated with bladder cancer risk4.013Citations (PDF)
109A Transcriptome-Wide Association Study Among 97,898 Women to Identify Candidate Susceptibility Genes for Epithelial Ovarian Cancer Risk
Cancer Research, 2018, 78, 5419-5430
3.864Citations (PDF)
110Role of the Complement System in Chronic Central Serous Chorioretinopathy
JAMA Ophthalmology, 2018, 136, 1128
6.170Citations (PDF)
111Variants in genes encoding small GTPases and association with epithelial ovarian cancer susceptibility
PLoS ONE, 2018, 13, e0197561
2.311Citations (PDF)
112rs495139 in the TYMS-ENOSF1 Region and Risk of Ovarian Carcinoma of Mucinous Histology4.43Citations (PDF)
113Identification of susceptibility pathways for the role of chromosome 15q25.1 in modifying lung cancer risk13.775Citations (PDF)
114Smoking intensity and bladder cancer aggressiveness at diagnosis
PLoS ONE, 2018, 13, e0194039
2.334Citations (PDF)
115Epidemiology, prevention, screening, diagnosis, and evaluation: update of the ICUD–SIU joint consultation on bladder cancer
World Journal of Urology, 2018, 37, 3-13
2.250Citations (PDF)
116Immediate treatment vs. active-surveillance in very-low-risk prostate cancer: the role of patient-, tumour-, and hospital-related factors4.05Citations (PDF)
117Identification of ADHD risk genes in extended pedigrees by combining linkage analysis and whole-exome sequencing
Molecular Psychiatry, 2018, 25, 2047-2057
7.818Citations (PDF)
118Enrichment of putative PAX8 target genes at serous epithelial ovarian cancer susceptibility loci
British Journal of Cancer, 2017, 116, 524-535
5.526Citations (PDF)
119Rare and low-frequency coding variants alter human adult height
Nature, 2017, 542, 186-190
37.9622Citations (PDF)
120Cohort Profile: The Nijmegen Biomedical Study (NBS)4.932Citations (PDF)
121A genome-wide association study yields five novel thyroid cancer risk loci13.7152Citations (PDF)
122Meta-analysis identifies novel risk loci and yields systematic insights into the biology of male-pattern baldness13.793Citations (PDF)
123Association Between Telomere Length and Risk of Cancer and Non-Neoplastic Diseases
JAMA Oncology, 2017, 3, 636
14.3476Citations (PDF)
124GLRB allelic variation associated with agoraphobic cognitions, increased startle response and fear network activation: a potential neurogenetic pathway to panic disorder
Molecular Psychiatry, 2017, 22, 1431-1439
7.856Citations (PDF)
125Description of the EuroTARGET cohort: A European collaborative project on TArgeted therapy in renal cell cancer—GEnetic- and tumor-related biomarkers for response and toxicity1.814Citations (PDF)
126Meta-Analysis of Genome-Wide Association Studies for Abdominal Aortic Aneurysm Identifies Four New Disease-Specific Risk Loci
Circulation Research, 2017, 120, 341-353
13.1222Citations (PDF)
127Population Modeling Integrating Pharmacokinetics, Pharmacodynamics, Pharmacogenetics, and Clinical Outcome in Patients With Sunitinib‐Treated Cancer2.730Citations (PDF)
128Large-scale association analysis identifies new lung cancer susceptibility loci and heterogeneity in genetic susceptibility across histological subtypes
Nature Genetics, 2017, 49, 1126-1132
25.2716Citations (PDF)
129Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer
Nature Genetics, 2017, 49, 680-691
25.2503Citations (PDF)
130A rare splice donor mutation in the haptoglobin gene associates with blood lipid levels and coronary artery disease
Human Molecular Genetics, 2017, 26, 2364-2376
2.922Citations (PDF)
131Identification of novel potential genetic predictors of urothelial bladder carcinoma susceptibility in Pakistani population
Familial Cancer, 2017, 16, 577-594
1.410Citations (PDF)
132Genetic variants associated with type 2 diabetes and adiposity and risk of intracranial and abdominal aortic aneurysms3.016Citations (PDF)
133History of hypertension, heart disease, and diabetes and ovarian cancer patient survival: evidence from the ovarian cancer association consortium
Cancer Causes and Control, 2017, 28, 469-486
1.731Citations (PDF)
134Whole-genome sequencing identifies rare genotypes in COMP and CHADL associated with high risk of hip osteoarthritis
Nature Genetics, 2017, 49, 801-805
25.291Citations (PDF)
135Pelvic Inflammatory Disease and the Risk of Ovarian Cancer and Borderline Ovarian Tumors: A Pooled Analysis of 13 Case-Control Studies3.377Citations (PDF)
136Genome-wide meta-analysis associates HLA-DQA1/DRB1 and LPA and lifestyle factors with human longevity13.7166Citations (PDF)
137Identification and replication of the interplay of four genetic high-risk variants for urinary bladder cancer
Carcinogenesis, 2017, 38, 1167-1179
2.821Citations (PDF)
138Sequence variant at 4q25 near PITX2 associates with appendicitis3.416Citations (PDF)
139Exome chip study provides novel insights into the genetics of pelvic organ prolapse0.90Citations (PDF)
140Ultra-sensitive Sequencing Identifies High Prevalence of Clonal Hematopoiesis-Associated Mutations throughout Adult Life6.5261Citations (PDF)
141Risk factors for second primary melanoma among Dutch patients with melanoma
British Journal of Dermatology, 2017, 176, 971-978
1.732Citations (PDF)
142Potential health gains for patients with metastatic renal cell carcinoma in daily clinical practice: A real-world cost-effectiveness analysis of sequential first- and second-line treatments
PLoS ONE, 2017, 12, e0177364
2.310Citations (PDF)
143Pleiotropy of genetic variants on obesity and smoking phenotypes: Results from the Oncoarray Project of The International Lung Cancer Consortium
PLoS ONE, 2017, 12, e0185660
2.315Citations (PDF)
144Autism spectrum disorders and autistic traits share genetics and biology
Molecular Psychiatry, 2017, 23, 1205-1212
7.8174Citations (PDF)
145Health-related quality of life and its determinants in patients with metastatic renal cell carcinoma
Quality of Life Research, 2017, 27, 115-124
2.160Citations (PDF)
146Protein-altering variants associated with body mass index implicate pathways that control energy intake and expenditure in obesity
Nature Genetics, 2017, 50, 26-41
25.2397Citations (PDF)
147Obesity, metabolic factors and risk of different histological types of lung cancer: A Mendelian randomization study
PLoS ONE, 2017, 12, e0177875
2.3106Citations (PDF)
148Independent Replication of Published Germline Polymorphisms Associated with Urinary Bladder Cancer Prognosis and Treatment Response
Bladder Cancer, 2016, 2, 77-89
0.527Citations (PDF)
149Variation in use of targeted therapies for metastatic renal cell carcinoma: Results from a Dutch population-based registry
BMC Cancer, 2016, 16,
2.99Citations (PDF)
150Meta-GWAS and Meta-Analysis of Exome Array Studies Do Not Reveal Genetic Determinants of Serum Hepcidin
PLoS ONE, 2016, 11, e0166628
2.35Citations (PDF)
151Adult body mass index and risk of ovarian cancer by subtype: a Mendelian randomization study4.983Citations (PDF)
152Follow-up in non–muscle-invasive bladder cancer—International Bladder Cancer Network recommendations1.871Citations (PDF)
153PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS
Journal of Medical Genetics, 2016, 53, 800-811
3.8208Citations (PDF)
154VariantASGR1Associated with a Reduced Risk of Coronary Artery Disease
New England Journal of Medicine, 2016, 374, 2131-2141
34.5189Citations (PDF)
155Survival in Patients With Primary Metastatic Renal Cell Carcinoma Treated With Sunitinib With or Without Previous Cytoreductive Nephrectomy: Results From a Population-based Registry
Urology, 2016, 95, 121-127
1.437Citations (PDF)
156Assessing the genetic architecture of epithelial ovarian cancer histological subtypes
Human Genetics, 2016, 135, 741-756
2.928Citations (PDF)
157Variants with large effects on blood lipids and the role of cholesterol and triglycerides in coronary disease
Nature Genetics, 2016, 48, 634-639
25.2248Citations (PDF)
158Genome-wide association study identifies 74 loci associated with educational attainment
Nature, 2016, 533, 539-542
37.91,382Citations (PDF)
159Cystatin C and Cardiovascular Disease2.3138Citations (PDF)
160Association of vitamin D levels and risk of ovarian cancer: a Mendelian randomization study4.9126Citations (PDF)
161Genetic Risk Can Be Decreased: Quitting Smoking Decreases and Delays Lung Cancer for Smokers With High and Low CHRNA5 Risk Genotypes — A Meta-Analysis
EBioMedicine, 2016, 11, 219-226
9.742Citations (PDF)
162Meta-analysis of the DRD5 VNTR in persistent ADHD1.06Citations (PDF)
163The clinical phenotype of hereditary versus sporadic prostate cancer: HPC definition revisited
Prostate, 2016, 76, 897-904
2.110Citations (PDF)
164Pleiotropic Analysis of Lung Cancer and Blood Triglycerides4.620Citations (PDF)
165Microhematuria assessment an IBCN consensus—Based upon a critical review of current guidelines1.829Citations (PDF)
166Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types
Cancer Discovery, 2016, 6, 1052-1067
25.1192Citations (PDF)
167Shared Genetic Risk Factors of Intracranial, Abdominal, and Thoracic Aneurysms4.050Citations (PDF)
168Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast–ovarian cancer susceptibility locus13.790Citations (PDF)
169Exome chip analyses in adult attention deficit hyperactivity disorder
Translational Psychiatry, 2016, 6, e923-e923
5.235Citations (PDF)
170Genetic variants linked to education predict longevity7.5126Citations (PDF)
171A rare missense mutation in CHRNA4 associates with smoking behavior and its consequences
Molecular Psychiatry, 2016, 21, 594-600
7.832Citations (PDF)
172Low awareness of risk factors among bladder cancer survivors: New evidence and a literature overview
European Journal of Cancer, 2016, 60, 136-145
4.940Citations (PDF)
173Assessment of Multifactor Gene–Environment Interactions and Ovarian Cancer Risk: Candidate Genes, Obesity, and Hormone-Related Risk Factors1.112Citations (PDF)
174Insertion of an SVA-E retrotransposon into theCASP8gene is associated with protection against prostate cancer
Human Molecular Genetics, 2016, 25, 1008-1018
2.929Citations (PDF)
175The association between socioeconomic status and tumour stage at diagnosis of ovarian cancer: A pooled analysis of 18 case-control studies
Cancer Epidemiology, 2016, 41, 71-79
2.026Citations (PDF)
176Identification of a novel susceptibility locus at 13q34 and refinement of the 20p12.2 region as a multi-signal locus associated with bladder cancer risk in individuals of European ancestry
Human Molecular Genetics, 2016, 25, 1203-1214
2.943Citations (PDF)
177Sequence variants in the PTCH1 gene associate with spine bone mineral density and osteoporotic fractures13.771Citations (PDF)
178BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers4.682Citations (PDF)
179Association of AADAC Deletion and Gilles de la Tourette Syndrome in a Large European Cohort
Biological Psychiatry, 2016, 79, 383-391
5.448Citations (PDF)
180Evidence of a genetic link between endometriosis and ovarian cancer
Fertility and Sterility, 2016, 105, 35-43.e10
2.947Citations (PDF)
181No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer
Gynecologic Oncology, 2016, 141, 386-401
3.020Citations (PDF)
182Evidence for three genetic loci involved in both anorexia nervosa risk and variation of body mass index
Molecular Psychiatry, 2016, 22, 192-201
7.870Citations (PDF)
183Trends in incidentie, prognose en sterfte bij spierinvasief blaascarcinoom
Tijdschrift Voor Urologie, 2015, 5, 184-192
0.12Citations (PDF)
184Epithelial‐Mesenchymal Transition (EMT) Gene Variants and Epithelial Ovarian Cancer (EOC) Risk
Genetic Epidemiology, 2015, 39, 689-697
3.123Citations (PDF)
185The Influence of Age and Sex on Genetic Associations with Adult Body Size and Shape: A Large-Scale Genome-Wide Interaction Study
PLoS Genetics, 2015, 11, e1005378
3.2402Citations (PDF)
186A Splice Region Variant in LDLR Lowers Non-high Density Lipoprotein Cholesterol and Protects against Coronary Artery Disease
PLoS Genetics, 2015, 11, e1005379
3.233Citations (PDF)
187Common Genetic Variation In Cellular Transport Genes and Epithelial Ovarian Cancer (EOC) Risk
PLoS ONE, 2015, 10, e0128106
2.347Citations (PDF)
188Polygenic risk scores for schizophrenia and bipolar disorder predict creativity
Nature Neuroscience, 2015, 18, 953-955
17.1421Citations (PDF)
189Cell-type-specific enrichment of risk-associated regulatory elements at ovarian cancer susceptibility loci
Human Molecular Genetics, 2015, 24, 3595-3607
2.947Citations (PDF)
190A Novel Risk Locus at 6p21.3 for Epstein–Barr Virus-Positive Hodgkin Lymphoma1.122Citations (PDF)
191Genetic studies of body mass index yield new insights for obesity biology
Nature, 2015, 518, 197-206
37.94,533Citations (PDF)
192Known susceptibility SNPs for sporadic prostate cancer show a similar association with “hereditary” prostate cancer
Prostate, 2015, 75, 474-483
2.112Citations (PDF)
193Identification of six new susceptibility loci for invasive epithelial ovarian cancer
Nature Genetics, 2015, 47, 164-171
25.2247Citations (PDF)
194Germline deletions in the tumour suppressor gene FOCAD are associated with polyposis and colorectal cancer development
Journal of Pathology, 2015, 236, 155-164
4.932Citations (PDF)
195Network-Based Integration of GWAS and Gene Expression Identifies a HOX -Centric Network Associated with Serous Ovarian Cancer Risk1.132Citations (PDF)
196The role of the prostate cancer gene 3 urine test in addition to serum prostate-specific antigen level in prostate cancer screening among breast cancer, early-onset gene mutation carriers1.88Citations (PDF)
197Genome-wide Analysis Identifies Novel Loci Associated with Ovarian Cancer Outcomes: Findings from the Ovarian Cancer Association Consortium
Clinical Cancer Research, 2015, 21, 5264-5276
6.838Citations (PDF)
198The proportion of postmenopausal breast cancer cases in the Netherlands attributable to lifestyle-related risk factors2.336Citations (PDF)
199Evaluating the ovarian cancer gonadotropin hypothesis: A candidate gene study
Gynecologic Oncology, 2015, 136, 542-548
3.018Citations (PDF)
200CHRNA5 Risk Variant Predicts Delayed Smoking Cessation and Earlier Lung Cancer Diagnosis—A Meta-Analysis4.677Citations (PDF)
201Urinary tract cancer survival in Europe 1999–2007: Results of the population-based study EUROCARE-5
European Journal of Cancer, 2015, 51, 2217-2230
4.985Citations (PDF)
202Cis-eQTL analysis and functional validation of candidate susceptibility genes for high-grade serous ovarian cancer13.770Citations (PDF)
203Associated Links Among Smoking, Chronic Obstructive Pulmonary Disease, and Small Cell Lung Cancer: A Pooled Analysis in the International Lung Cancer Consortium
EBioMedicine, 2015, 2, 1677-1685
9.778Citations (PDF)
204Common variants at theCHEK2gene locus and risk of epithelial ovarian cancer
Carcinogenesis, 2015, 36, 1341-1353
2.828Citations (PDF)
205Shared genetics underlying epidemiological association between endometriosis and ovarian cancer
Human Molecular Genetics, 2015, 24, 5955-5964
2.978Citations (PDF)
206Iron and hepcidin as risk factors in atherosclerosis: what do the genes say?
BMC Genetics, 2015, 16,
2.830Citations (PDF)
207The effect of smoking and timing of smoking cessation on clinical outcome in non–muscle-invasive bladder cancer1.839Citations (PDF)
208Dermatological exposure to coal tar and bladder cancer risk: A case-control study1.818Citations (PDF)
209The prognostic value of family history among patients with urinary bladder cancer
International Journal of Cancer, 2015, 136, 1117-1124
4.321Citations (PDF)
210Prognostic Factors and Risk Groups in T1G3 Non–Muscle-invasive Bladder Cancer Patients Initially Treated with Bacillus Calmette-Guérin: Results of a Retrospective Multicenter Study of 2451 Patients
European Urology, 2015, 67, 74-82
2.1227Citations (PDF)
211TYK2 Protein-Coding Variants Protect against Rheumatoid Arthritis and Autoimmunity, with No Evidence of Major Pleiotropic Effects on Non-Autoimmune Complex Traits
PLoS ONE, 2015, 10, e0122271
2.3151Citations (PDF)
212Common Genetic Variation in Circadian Rhythm Genes and Risk of Epithelial Ovarian Cancer (EOC)0.030Citations (PDF)
213A Comparison of Multivariate Genome-Wide Association Methods
PLoS ONE, 2014, 9, e95923
2.3184Citations (PDF)
214Markedly increased incidence and improved survival of testicular cancer in the Netherlands
Acta Oncológica, 2014, 53, 342-350
1.828Citations (PDF)
215Genome-Wide Association Study of Intracranial Aneurysm Identifies a New Association on Chromosome 7
Stroke, 2014, 45, 3194-3199
5.960Citations (PDF)
216NOD2 is dispensable for ATG16L1 deficiency-mediated resistance to urinary tract infection
Autophagy, 2014, 10, 331-338
13.716Citations (PDF)
217Autophagy Controls BCG-Induced Trained Immunity and the Response to Intravesical BCG Therapy for Bladder Cancer
PLoS Pathogens, 2014, 10, e1004485
4.4212Citations (PDF)
218Identification of Novel Genetic Loci Associated with Thyroid Peroxidase Antibodies and Clinical Thyroid Disease
PLoS Genetics, 2014, 10, e1004123
3.2178Citations (PDF)
219High Risk Population Isolate Reveals Low Frequency Variants Predisposing to Intracranial Aneurysms
PLoS Genetics, 2014, 10, e1004134
3.258Citations (PDF)
220Hormonale en reproductieve factoren in de ontwikkeling van blaaskanker
Tijdschrift Voor Urologie, 2014, 4, 139-143
0.10Citations (PDF)
221New insights into the aetiology of scrotal cancer, a nationwide case‐control study in the Netherlands2.211Citations (PDF)
222Flavonoid and lignan intake in relation to bladder cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) study
British Journal of Cancer, 2014, 111, 1870-1880
5.557Citations (PDF)
223Reproducibility of self-reported melanoma risk factors in melanoma patients
Melanoma Research, 2014, 24, 592-601
1.511Citations (PDF)
224Risk of Ovarian Cancer and the NF-κB Pathway: Genetic Association with IL1A and TNFSF10
Cancer Research, 2014, 74, 852-861
3.859Citations (PDF)
225Serum Hepcidin Is Associated With Presence of Plaque in Postmenopausal Women of a General Population6.047Citations (PDF)
226Common variant at 16p11.2 conferring risk of psychosis
Molecular Psychiatry, 2014, 19, 108-114
7.897Citations (PDF)
227Targeted Prostate Cancer Screening in BRCA1 and BRCA2 Mutation Carriers: Results from the Initial Screening Round of the IMPACT Study
European Urology, 2014, 66, 489-499
2.1222Citations (PDF)
228Novel loci affecting iron homeostasis and their effects in individuals at risk for hemochromatosis13.7250Citations (PDF)
229Combining risk markers improves cardiovascular risk prediction in women
Clinical Science, 2014, 126, 139-146
6.214Citations (PDF)
230Self-reported acne is not associated with prostate cancer1.85Citations (PDF)
231Current concepts—Future needs: The 10th Annual Meeting of the International Bladder Cancer Network (IBCN) in Nijmegen, The Netherlands, September 20th to 22nd, 20121.80Citations (PDF)
232Patient and Disease Characteristics are Important Determinants of Health-Related Quality of Life of Patients with Metastatic Renal Cell Carcinoma Results from a Population-Based Registry
Value in Health, 2014, 17, A649
1.91Citations (PDF)
233Consortium analysis of gene and gene–folate interactions in purine and pyrimidine metabolism pathways with ovarian carcinoma risk4.018Citations (PDF)
234Impact of mitotic activity on the pathological substaging of pT1 cutaneous melanoma
British Journal of Dermatology, 2014, 170, 874-877
1.78Citations (PDF)
235Molecular markers for urothelial bladder cancer prognosis: Toward implementation in clinical practice1.844Citations (PDF)
236Genome-wide association study yields variants at 20p12.2 that associate with urinary bladder cancer
Human Molecular Genetics, 2014, 23, 5545-5557
2.954Citations (PDF)
237Defining the role of common variation in the genomic and biological architecture of adult human height
Nature Genetics, 2014, 46, 1173-1186
25.21,982Citations (PDF)
238Limited role for histopathological examination of re-excision specimens of completely excised melanomas2.910Citations (PDF)
239Harmonization of Neuroticism and Extraversion phenotypes across inventories and cohorts in the Genetics of Personality Consortium: an application of Item Response Theory
Behavior Genetics, 2014, 44, 295-313
1.3118Citations (PDF)
240Prognostic factors for survival in metastatic breast cancer by hormone receptor status2.327Citations (PDF)
241A meta-analysis of Hodgkin lymphoma reveals 19p13.3 TCF3 as a novel susceptibility locus13.784Citations (PDF)
242Recurrent urinary tract infection and risk of bladder cancer in the Nijmegen bladder cancer study
British Journal of Cancer, 2014, 112, 594-600
5.5110Citations (PDF)
243Case–Control Genome-Wide Association Study of Persistent Attention-Deficit Hyperactivity Disorder Identifies FBXO33 as a Novel Susceptibility Gene for the Disorder
Neuropsychopharmacology, 2014, 40, 915-926
5.464Citations (PDF)
244Prognostic Relevance of Urinary Bladder Cancer Susceptibility Loci
PLoS ONE, 2014, 9, e89164
2.324Citations (PDF)
245Macronutrient intake and risk of urothelial cell carcinoma in the European prospective investigation into cancer and nutrition4.338Citations (PDF)
246The effect of demographic and lifestyle changes on the burden of breast cancer in Iranian women: A projection to 2030
Breast, 2013, 22, 277-281
2.353Citations (PDF)
247Meta-analysis of Gene-Level Associations for Rare Variants Based on Single-Variant Statistics6.565Citations (PDF)
248Impact of Inherited Genetic Variants Associated With Lipid Profile, Hypertension, and Coronary Artery Disease on the Risk of Intracranial and Abdominal Aortic Aneurysms3.829Citations (PDF)
249GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer
Nature Genetics, 2013, 45, 362-370
25.2349Citations (PDF)
250Risk of prostate cancer among cancer survivors in the Netherlands
Cancer Epidemiology, 2013, 37, 140-145
2.08Citations (PDF)
251Shared and unique genetic contributions to attention deficit/hyperactivity disorder and substance use disorders: A pilot study of six candidate genes1.040Citations (PDF)
252Trends in incidence and survival of Dutch women with vulvar squamous cell carcinoma
European Journal of Cancer, 2013, 49, 3872-3880
4.9139Citations (PDF)
253Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer
Nature Genetics, 2013, 45, 371-384
25.2523Citations (PDF)
254Cigarette smoking and risk of ovarian cancer: a pooled analysis of 21 case–control studies
Cancer Causes and Control, 2013, 24, 989-1004
1.799Citations (PDF)
255Androgenetic Alopecia: Identification of Four Genetic Risk Loci and Evidence for the Contribution of WNT Signaling to Its Etiology2.3114Citations (PDF)
256Epidemiology and Risk Factors of Urothelial Bladder Cancer
European Urology, 2013, 63, 234-241
2.11,914Citations (PDF)
257The Cost-Effectiveness of Sequential First- and Second-Line Treatments in Metastatic Renal Cell Carcinoma Using Real-World Data and a Patient-Level Simulation Model
Value in Health, 2013, 16, A587
1.90Citations (PDF)
258Cancer incidence in Dutch Balkan veterans
Cancer Epidemiology, 2013, 37, 550-555
2.023Citations (PDF)
259Common genetic loci influencing plasma homocysteine concentrations and their effect on risk of coronary artery disease4.7194Citations (PDF)
260Melanoma of unknown primary origin: A population-based study in the Netherlands
European Journal of Cancer, 2013, 49, 676-683
4.945Citations (PDF)
261Continuous vs. intermittent androgen deprivation therapy for metastatic prostate cancer1.852Citations (PDF)
262A variant in FTO shows association with melanoma risk not due to BMI
Nature Genetics, 2013, 45, 428-432
25.2124Citations (PDF)
263Genome-wide meta-analysis identifies 11 new loci for anthropometric traits and provides insights into genetic architecture
Nature Genetics, 2013, 45, 501-512
25.2659Citations (PDF)
264Identification of heart rate–associated loci and their effects on cardiac conduction and rhythm disorders
Nature Genetics, 2013, 45, 621-631
25.2309Citations (PDF)
265Increased paternal age and the influence on burden of genomic copy number variation in the general population
Human Genetics, 2013, 132, 443-450
2.940Citations (PDF)
266Sex-stratified Genome-wide Association Studies Including 270,000 Individuals Show Sexual Dimorphism in Genetic Loci for Anthropometric Traits
PLoS Genetics, 2013, 9, e1003500
3.2423Citations (PDF)
267A Meta-Analysis of Thyroid-Related Traits Reveals Novel Loci and Gender-Specific Differences in the Regulation of Thyroid Function
PLoS Genetics, 2013, 9, e1003266
3.2216Citations (PDF)
268Urinary Bladder Cancer Susceptibility Markers. What Do We Know about Functional Mechanisms?4.434Citations (PDF)
269A Variant in LDLR Is Associated With Abdominal Aortic Aneurysm3.891Citations (PDF)
270Associations of common variants in HFE and TMPRSS6 with iron parameters are independent of serum hepcidin in a general population: a replication study
Journal of Medical Genetics, 2013, 50, 593-598
3.837Citations (PDF)
271A common variant at 8q24.21 is associated with renal cell cancer13.758Citations (PDF)
272Combined and Interactive Effects of Environmental and GWAS-Identified Risk Factors in Ovarian Cancer1.158Citations (PDF)
273A rare nonsynonymous sequence variant in C3 is associated with high risk of age-related macular degeneration
Nature Genetics, 2013, 45, 1371-1374
25.2134Citations (PDF)
274Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer13.7155Citations (PDF)
275Tubal ligation and risk of ovarian cancer subtypes: a pooled analysis of case-control studies4.9159Citations (PDF)
276Identification and molecular characterization of a new ovarian cancer susceptibility locus at 17q21.3113.7108Citations (PDF)
277Efficacy of a Regional Network for Ovarian Cancer Care
Obstetrics and Gynecology, 2013, 122, 668-675
1.918Citations (PDF)
278Genome-wide association study of subtype-specific epithelial ovarian cancer risk alleles using pooled DNA
Human Genetics, 2013, 133, 481-497
2.924Citations (PDF)
279CHEK2*1100delC homozygosity in the Netherlands—prevalence and risk of breast and lung cancer3.037Citations (PDF)
280A Meta-Analysis Of Hodgkin Lymphoma Reveals 19p13.3 (TCF3) As a Novel Susceptibility Loc
Blood, 2013, 122, 626-626
4.80Citations (PDF)
281Six Novel Susceptibility Loci for Early-Onset Androgenetic Alopecia and Their Unexpected Association with Common Diseases
PLoS Genetics, 2012, 8, e1002746
3.2120Citations (PDF)
282Is There a Relationship Between Fatigue Perception and the Serum Levels of Thyrotropin and Free Thyroxine in Euthyroid Subjects?
Thyroid, 2012, 22, 1236-1243
4.433Citations (PDF)
283Risk and prognostic significance of metachronous contralateral testicular germ cell tumours
British Journal of Cancer, 2012, 107, 1637-1643
5.530Citations (PDF)
284Plasma carotenoids and vitamin C concentrations and risk of urothelial cell carcinoma in the European Prospective Investigation into Cancer and Nutrition4.745Citations (PDF)
285Why do Women With Double Primary Carcinoma of the Endometrium and Ovary Have a Favorable Prognosis?1.311Citations (PDF)
286Genome-Wide Association Study of Classical Hodgkin Lymphoma and Epstein–Barr Virus Status–Defined Subgroups4.6158Citations (PDF)
287A study based on whole-genome sequencing yields a rare variant at 8q24 associated with prostate cancer
Nature Genetics, 2012, 44, 1326-1329
25.2184Citations (PDF)
288Histological type is not an independent prognostic factor for the risk pattern of breast cancer recurrences2.331Citations (PDF)
289Adequacy of family history taking in ovarian cancer patients: a population-based study
Familial Cancer, 2012, 11, 343-349
1.414Citations (PDF)
290DNA adducts in skin biopsies and 1-hydroxypyrene in urine of psoriasis patients and healthy volunteers following treatment with coal tar
Toxicology Letters, 2012, 213, 39-44
0.615Citations (PDF)
291Discrepancy between clinical staging through bimanual palpation and pathological staging after cystectomy1.844Citations (PDF)
292Genome-wide meta-analysis of common variant differences between men and women
Human Molecular Genetics, 2012, 21, 4805-4815
2.939Citations (PDF)
293Association Between Chromosome 9p21 Variants and the Ankle-Brachial Index Identified by a Meta-Analysis of 21 Genome-Wide Association Studies3.8112Citations (PDF)
294Modest improvement in 20years of kidney cancer care in the Netherlands
European Journal of Cancer, 2012, 48, 1822-1830
4.98Citations (PDF)
295Increased risk of lung cancer in individuals with a family history of the disease: A pooled analysis from the International Lung Cancer Consortium
European Journal of Cancer, 2012, 48, 1957-1968
4.9181Citations (PDF)
296FTO genotype is associated with phenotypic variability of body mass index
Nature, 2012, 490, 267-272
37.9432Citations (PDF)
297Association between thyroid function, thyroid autoimmunity, and state and trait factors of depression
Acta Psychiatrica Scandinavica, 2012, 126, 377-384
4.164Citations (PDF)
298Replication Study and Meta-Analysis in European Samples Supports Association of the 3p21.1 Locus with Bipolar Disorder
Biological Psychiatry, 2012, 72, 645-650
5.415Citations (PDF)
299Fruit and vegetable consumption and risk of aggressive and non-aggressive urothelial cell carcinomas in the European Prospective Investigation into Cancer and Nutrition
European Journal of Cancer, 2012, 48, 3267-3277
4.929Citations (PDF)
300The Clinical Epidemiology of Urachal Carcinoma: Results of a Large, Population Based Study
Journal of Urology, 2012, 188, 1102-1107
4.2165Citations (PDF)
301Discovery of common variants associated with low TSH levels and thyroid cancer risk
Nature Genetics, 2012, 44, 319-322
25.2228Citations (PDF)
302Progress against cancer in the Netherlands since the late 1980s: An epidemiological evaluation
International Journal of Cancer, 2012, 130, 2981-2989
4.339Citations (PDF)
303Detection of mitochondrial deoxyribonucleic acid alterations in urine from urothelial cell carcinoma patients4.325Citations (PDF)
304Personal hair dye use and the risk of bladder cancer: a case–control study from The Netherlands
Cancer Causes and Control, 2012, 23, 1139-1148
1.735Citations (PDF)
305Trends in therapy and survival of advanced stage epithelial ovarian cancer patients in the Netherlands
Gynecologic Oncology, 2012, 125, 649-654
3.046Citations (PDF)
306Health inequalities in the Netherlands: a cross-sectional study of the role of Type D (distressed) personality
BMC Public Health, 2012, 12,
3.115Citations (PDF)
307Occupation and scrotal cancer: Results of the NOCCA study
Acta Oncológica, 2011, 50, 1244-1246
1.86Citations (PDF)
308Serum hepcidin: reference ranges and biochemical correlates in the general population
Blood, 2011, 117, e218-e225
4.8266Citations (PDF)
309Common variants at VRK2 and TCF4 conferring risk of schizophrenia
Human Molecular Genetics, 2011, 20, 4076-4081
2.9200Citations (PDF)
310PCN183 A Population-Based Registry for the Evaluation of New Treatment Options for Patients with Metastatic Renal Cell Carcinoma
Value in Health, 2011, 14, A467-A468
1.90Citations (PDF)
311Mutations in BRIP1 confer high risk of ovarian cancer
Nature Genetics, 2011, 43, 1104-1107
25.2364Citations (PDF)
312A germline variant in the TP53 polyadenylation signal confers cancer susceptibility
Nature Genetics, 2011, 43, 1098-1103
25.2282Citations (PDF)
313Identification of low-frequency variants associated with gout and serum uric acid levels
Nature Genetics, 2011, 43, 1127-1130
25.2144Citations (PDF)
314Better survival in patients with metastasised kidney cancer after nephrectomy: A population-based study in the Netherlands
European Journal of Cancer, 2011, 47, 2023-2032
4.938Citations (PDF)
315Risk of colorectal and endometrial cancers in EPCAM deletion-positive Lynch syndrome: a cohort study
Lancet Oncology, The, 2011, 12, 49-55
27.4264Citations (PDF)
316Blood lipid levels and prostate cancer risk; a cohort study4.061Citations (PDF)
317Functional Polymorphisms in the TERT Promoter Are Associated with Risk of Serous Epithelial Ovarian and Breast Cancers
PLoS ONE, 2011, 6, e24987
2.354Citations (PDF)
318Reply
American Journal of Roentgenology, 2011, 197, W369-W370
4.10Citations (PDF)
319Effect of tyrosine kinase inhibitor treatment of renal cell carcinoma on the accumulation of carbonic anhydrase IX‐specific chimeric monoclonal antibody cG250
BJU International, 2011, 107, 118-125
3.220Citations (PDF)
320Targeted prostate cancer screening in men with mutations in BRCA1 and BRCA2 detects aggressive prostate cancer: preliminary analysis of the results of the IMPACT study
BJU International, 2011, 107, 28-39
3.287Citations (PDF)
321Periprostatic fat correlates with tumour aggressiveness in prostate cancer patients
BJU International, 2011, 107, 1775-1779
3.297Citations (PDF)
322Quantification of extraprostatic extension in prostate cancer: different parameters correlated to biochemical recurrence after radical prostatectomy
Histopathology, 2011, 59, 692-702
3.622Citations (PDF)
323A rare variant in MYH6 is associated with high risk of sick sinus syndrome
Nature Genetics, 2011, 43, 316-320
25.2290Citations (PDF)
324Cancer risk in patients with Noonan syndrome carrying a PTPN11 mutation3.0172Citations (PDF)
325The Epidemiology of Renal Cell Carcinoma
European Urology, 2011, 60, 615-621
2.1888Citations (PDF)
326Prognostic Factors for Survival in Patients With Recurrence of Muscle Invasive Bladder Cancer After Treatment With Curative Intent2.315Citations (PDF)
327Abdominal Aortic Aneurysm Is Associated with a Variant in Low-Density Lipoprotein Receptor-Related Protein 16.5212Citations (PDF)
328Exploring DRD4 and its interaction with SLC6A3 as possible risk factors for adult ADHD: A meta‐analysis in four European populations1.523Citations (PDF)
329Fluid intake and the risk of urothelial cell carcinomas in the European Prospective Investigation into Cancer and Nutrition (EPIC)
International Journal of Cancer, 2011, 128, 2695-2708
4.365Citations (PDF)
330Variety in vegetable and fruit consumption and risk of bladder cancer in the European Prospective Investigation into Cancer and Nutrition
International Journal of Cancer, 2011, 128, 2971-2979
4.331Citations (PDF)
331Underestimation of Effect of Thyroid Function Parameters on Morbidity and Mortality due to Intra-Individual Variation4.015Citations (PDF)
332Maternally Derived Microduplications at 15q11-q13: Implication of Imprinted Genes in Psychotic Illness
American Journal of Psychiatry, 2011, 168, 408-417
8.8109Citations (PDF)
333Sequence variants at CYP1A1–CYP1A2 and AHR associate with coffee consumption
Human Molecular Genetics, 2011, 20, 2071-2077
2.9136Citations (PDF)
334A genetic variant near the PMAIP1/Noxa gene is associated with increased bleomycin sensitivity
Human Molecular Genetics, 2011, 20, 820-826
2.911Citations (PDF)
335The Role of KRAS rs61764370 in Invasive Epithelial Ovarian Cancer: Implications for Clinical Testing
Clinical Cancer Research, 2011, 17, 3742-3750
6.848Citations (PDF)
336Genome-Wide Significant Association Between a Sequence Variant at 15q15.2 and Lung Cancer Risk
Cancer Research, 2011, 71, 1356-1361
3.827Citations (PDF)
337The validity of the mortality to incidence ratio as a proxy for site-specific cancer survival0.3191Citations (PDF)
338Introduction of the CKD-EPI equation to estimate glomerular filtration rate in a Caucasian population0.899Citations (PDF)
339Risk HLA-DQA1 and PLA 2 R1 Alleles in Idiopathic Membranous Nephropathy34.5491Citations (PDF)
340European genome-wide association study identifies SLC14A1 as a new urinary bladder cancer susceptibility gene
Human Molecular Genetics, 2011, 20, 4268-4281
2.9146Citations (PDF)
341DIRAS2 is Associated with Adult ADHD, Related Traits, and Co-Morbid Disorders
Neuropsychopharmacology, 2011, 36, 2318-2327
5.452Citations (PDF)
342Genome-wide association analysis of coffee drinking suggests association with CYP1A1/CYP1A2 and NRCAM
Molecular Psychiatry, 2011, 17, 1116-1129
7.8126Citations (PDF)
343Urologists’ and GPs’ knowledge of hereditary prostate cancer is suboptimal for prostate cancer counseling: a nation-wide survey in The Netherlands
Familial Cancer, 2011, 11, 195-200
1.46Citations (PDF)
344Prognostic relevance of number and bilaterality of positive surgical margins after radical prostatectomy
World Journal of Urology, 2011, 30, 105-110
2.224Citations (PDF)
345Polymorphisms in Stromal Genes and Susceptibility to Serous Epithelial Ovarian Cancer: A Report from the Ovarian Cancer Association Consortium
PLoS ONE, 2011, 6, e19642
2.35Citations (PDF)
346Ultrasound Detection of Rotator Cuff Tears: Observer Agreement Related to Increasing Experience
American Journal of Roentgenology, 2010, 195, W440-W446
4.154Citations (PDF)
347Common variants in the TPH1 and TPH2 regions are not associated with persistent ADHD in a combined sample of 1,636 adult cases and 1,923 controls from four European populations1.524Citations (PDF)
348Unsuspected sonographic findings in patients with posttraumatic shoulder complaints1.111Citations (PDF)
349An international multicenter association study of the serotonin transporter gene in persistent ADHD
Genes, Brain and Behavior, 2010, 9, 449-458
2.356Citations (PDF)
350No Increased Risk of Cancer after Coal Tar Treatment in Patients with Psoriasis or Eczema2.395Citations (PDF)
351Hundreds of variants clustered in genomic loci and biological pathways affect human height
Nature, 2010, 467, 832-838
37.91,887Citations (PDF)
352The length of positive surgical margins correlates with biochemical recurrence after radical prostatectomy
Histopathology, 2010, 56, 464-471
3.655Citations (PDF)
353A sequence variant at 4p16.3 confers susceptibility to urinary bladder cancer
Nature Genetics, 2010, 42, 415-419
25.2178Citations (PDF)
354Sequence variants at CHRNB3–CHRNA6 and CYP2A6 affect smoking behavior
Nature Genetics, 2010, 42, 448-453
25.2677Citations (PDF)
355Genome-wide association study identifies a sequence variant within the DAB2IP gene conferring susceptibility to abdominal aortic aneurysm
Nature Genetics, 2010, 42, 692-697
25.2204Citations (PDF)
356Common variants at 19p13 are associated with susceptibility to ovarian cancer
Nature Genetics, 2010, 42, 880-884
25.2251Citations (PDF)
357A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24
Nature Genetics, 2010, 42, 874-879
25.2341Citations (PDF)
358Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index
Nature Genetics, 2010, 42, 937-948
25.22,795Citations (PDF)
359A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility loci
Nature Genetics, 2010, 42, 978-984
25.2524Citations (PDF)
360Body mass index is not a prognostic marker for prostate‐specific antigen failure and survival in Dutch men treated with brachytherapy
BJU International, 2010, 105, 42-48
3.231Citations (PDF)
361Replication of Lung Cancer Susceptibility Loci at Chromosomes 15q25, 5p15, and 6p21: A Pooled Analysis From the International Lung Cancer Consortium4.6179Citations (PDF)
362A large genome scan for rare CNVs in amyotrophic lateral sclerosis
Human Molecular Genetics, 2010, 19, 4091-4099
2.958Citations (PDF)
363Variety in Fruit and Vegetable Consumption and the Risk of Lung Cancer in the European Prospective Investigation into Cancer and Nutrition1.181Citations (PDF)
364Genetics of Hypospadias: Are Single-Nucleotide Polymorphisms inSRD5A2,ESR1,ESR2, andATF3Really Associated with the Malformation?4.047Citations (PDF)
365Genetic Correction of PSA Values Using Sequence Variants Associated with PSA Levels12.5148Citations (PDF)
366Risk of urothelial bladder cancer in Lynch syndrome is increased, in particular among MSH2 mutation carriers
Journal of Medical Genetics, 2010, 47, 464-470
3.8190Citations (PDF)
367Germline Genetic Markers for Urinary Bladder Cancer Risk, Prognosis and Treatment Response
Future Oncology, 2010, 6, 1433-1460
2.316Citations (PDF)
368Association of Variants at UMOD with Chronic Kidney Disease and Kidney Stones—Role of Age and Comorbid Diseases
PLoS Genetics, 2010, 6, e1001039
3.2187Citations (PDF)
369Explanations for worsening cancer survival70.725Citations (PDF)
370Dutasteride and Prostate Cancer34.54Citations (PDF)
371Clinical Epidemiology of Nonurothelial Bladder Cancer: Analysis of The Netherlands Cancer Registry
Journal of Urology, 2010, 183, 915-920
4.2108Citations (PDF)
372Prostate cancer: Trends in incidence, survival and mortality in the Netherlands, 1989–2006
European Journal of Cancer, 2010, 46, 2077-2087
4.958Citations (PDF)
373Androgenic alopecia is not useful as an indicator of men at high risk of prostate cancer
European Journal of Cancer, 2010, 46, 3294-3299
4.934Citations (PDF)
374Efficacy and tolerance of salvage radiotherapy after radical prostatectomy, with emphasis on high-risk patients suited for adjuvant radiotherapy
Radiotherapy and Oncology, 2010, 97, 467-473
2.022Citations (PDF)
375Common variants in DGKK are strongly associated with risk of hypospadias
Nature Genetics, 2010, 43, 48-50
25.2106Citations (PDF)
376Genome-wide association study of renal cell carcinoma identifies two susceptibility loci on 2p21 and 11q13.3
Nature Genetics, 2010, 43, 60-65
25.2230Citations (PDF)
377Expanding the range of ZNF804A variants conferring risk of psychosis
Molecular Psychiatry, 2010, 16, 59-66
7.8145Citations (PDF)
378Body mass index is not a predictor of biochemical recurrence after radical prostatectomy in Dutch men diagnosed with prostate cancer
World Journal of Urology, 2010, 29, 695-701
2.213Citations (PDF)
379Ancestry-Shift Refinement Mapping of the C6orf97-ESR1 Breast Cancer Susceptibility Locus
PLoS Genetics, 2010, 6, e1001029
3.285Citations (PDF)
380Disruption of the neurexin 1 gene is associated with schizophrenia
Human Molecular Genetics, 2009, 18, 988-996
2.9446Citations (PDF)
381Physical activity and risk of prostate cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort4.381Citations (PDF)
382Consumption of vegetables and fruit and the risk of bladder cancer in the European Prospective Investigation into Cancer and Nutrition
International Journal of Cancer, 2009, 125, 2643-2651
4.345Citations (PDF)
383The present and future burden of urinary bladder cancer in the world
World Journal of Urology, 2009, 27, 289-293
2.2823Citations (PDF)
384Common variants conferring risk of schizophrenia
Nature, 2009, 460, 744-747
37.91,662Citations (PDF)
385Sequence variants at the TERT-CLPTM1L locus associate with many cancer types
Nature Genetics, 2009, 41, 221-227
25.2598Citations (PDF)
386Genome-wide association study identifies sequence variants on 6q21 associated with age at menarche
Nature Genetics, 2009, 41, 734-738
25.2207Citations (PDF)
387Sequence variants in the CLDN14 gene associate with kidney stones and bone mineral density
Nature Genetics, 2009, 41, 926-930
25.2285Citations (PDF)
388New common variants affecting susceptibility to basal cell carcinoma
Nature Genetics, 2009, 41, 909-914
25.2314Citations (PDF)
389Genetic variation in the prostate stem cell antigen gene PSCA confers susceptibility to urinary bladder cancer
Nature Genetics, 2009, 41, 991-995
25.2331Citations (PDF)
390Genome-wide association study identifies 19p13.3 (UNC13A) and 9p21.2 as susceptibility loci for sporadic amyotrophic lateral sclerosis
Nature Genetics, 2009, 41, 1083-1087
25.2388Citations (PDF)
391Genome-wide association and replication studies identify four variants associated with prostate cancer susceptibility
Nature Genetics, 2009, 41, 1122-1126
25.2322Citations (PDF)
392Body mass index as a prognostic marker for biochemical recurrence in Dutch men treated with radical prostatectomy
BJU International, 2009, 104, 321-325
3.224Citations (PDF)
393Changes in Prostate Shape and Volume and Their Implications for Radiotherapy After Introduction of Endorectal Balloon as Determined by MRI at 3T1.553Citations (PDF)
394A single institution experience with biochemical recurrence after radical prostatectomy for tumors that on pathology are of small volume or “insignificant”1.815Citations (PDF)
395A philosophical perspective supports the need for patient-outcome studies in diagnostic test evaluation3.712Citations (PDF)
396Genome-wide association studies in bladder cancer: first results and potential relevance
Current Opinion in Urology, 2009, 19, 540-546
2.022Citations (PDF)
397Detection of rotator cuff tears: the value of MRI following ultrasound
European Radiology, 2009, 20, 450-457
3.692Citations (PDF)
398Periprostatic fat measured on computed tomography as a marker for prostate cancer aggressiveness
World Journal of Urology, 2009, 28, 699-704
2.240Citations (PDF)
399Fruits and vegetables consumption and the risk of histological subtypes of lung cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC)
Cancer Causes and Control, 2009, 21, 357-371
1.779Citations (PDF)
400Multicenter Analysis of the SLC6A3/DAT1 VNTR Haplotype in Persistent ADHD Suggests Differential Involvement of the Gene in Childhood and Persistent ADHD
Neuropsychopharmacology, 2009, 35, 656-664
5.4189Citations (PDF)
401Copy number variations of chromosome 16p13.1 region associated with schizophrenia
Molecular Psychiatry, 2009, 16, 17-25
7.8242Citations (PDF)
402Expert review remains important in the histopathological diagnosis of cutaneous melanocytic lesions
Histopathology, 2008, 52, 139-146
3.658Citations (PDF)
403Maximum tumor diameter is not an independent prognostic factor in high-risk localized prostate cancer
World Journal of Urology, 2008, 26, 237-241
2.227Citations (PDF)
404Gender differences in the trend of colorectal cancer incidence in Singapore, 1968–20021.835Citations (PDF)
405Testicular cancer: Marked birth cohort effects on incidence and a decline in mortality in southern Netherlands since 19704.322Citations (PDF)
406Screening for prostate cancer in Dutch hereditary prostate cancer families4.319Citations (PDF)
407Association of the dopamine transporter (SLC6A3/DAT1) gene 9–6 haplotype with adult ADHD1.578Citations (PDF)
408A variant associated with nicotine dependence, lung cancer and peripheral arterial disease
Nature, 2008, 452, 638-642
37.91,459Citations (PDF)
409Large recurrent microdeletions associated with schizophrenia
Nature, 2008, 455, 232-236
37.91,674Citations (PDF)
410Many sequence variants affecting diversity of adult human height
Nature Genetics, 2008, 40, 609-615
25.2642Citations (PDF)
411Common variants on chromosome 5p12 confer susceptibility to estrogen receptor–positive breast cancer
Nature Genetics, 2008, 40, 703-706
25.2419Citations (PDF)
412Two newly identified genetic determinants of pigmentation in Europeans
Nature Genetics, 2008, 40, 835-837
25.2354Citations (PDF)
413ASIP and TYR pigmentation variants associate with cutaneous melanoma and basal cell carcinoma
Nature Genetics, 2008, 40, 886-891
25.2335Citations (PDF)
414Sequence variant on 8q24 confers susceptibility to urinary bladder cancer
Nature Genetics, 2008, 40, 1307-1312
25.2389Citations (PDF)
415Male-pattern baldness susceptibility locus at 20p11
Nature Genetics, 2008, 40, 1282-1284
25.2132Citations (PDF)
416Common sequence variants on 2p15 and Xp11.22 confer susceptibility to prostate cancer
Nature Genetics, 2008, 40, 281-283
25.2365Citations (PDF)
417Components of the plasminogen activator system and their complexes in renal cell and bladder cancer: comparison between normal and matched cancerous tissues
BJU International, 2008, 102, 177-182
3.219Citations (PDF)
418The prognostic role of the pathological T2 subclassification for prostate cancer in the 2002 Tumour‐Nodes‐Metastasis staging system
BJU International, 2008, 102, 438-441
3.223Citations (PDF)
419The effect on pain experienced by male patients of watching their office‐based flexible cystoscopy
BJU International, 2008, 102, 1445-1446
3.229Citations (PDF)
420Epidemiology and genetic susceptibility to bladder cancer
BJU International, 2008, 102, 1207-1215
3.263Citations (PDF)
421Polymorphisms in the H19 Gene and the Risk of Bladder Cancer
European Urology, 2008, 54, 1118-1126
2.1136Citations (PDF)
422No improvement in renal cell carcinoma survival: A population-based study in the Netherlands
European Journal of Cancer, 2008, 44, 1701-1709
4.920Citations (PDF)
423Animal foods, protein, calcium and prostate cancer risk: the European Prospective Investigation into Cancer and Nutrition
British Journal of Cancer, 2008, 98, 1574-1581
5.5165Citations (PDF)
424Circulating Concentrations of Folate and Vitamin B12 in Relation to Prostate Cancer Risk: Results from the European Prospective Investigation into Cancer and Nutrition Study1.154Citations (PDF)
425Hereditary bladder cancer1.130Citations (PDF)
426Alcohol Consumption and Mutations or Promoter Hypermethylation of thevon Hippel–LindauGene in Renal Cell Carcinoma1.19Citations (PDF)
427Fatty acid composition of plasma phospholipids and risk of prostate cancer in a case-control analysis nested within the European Prospective Investigation into Cancer and Nutrition4.7139Citations (PDF)
428Plasma selenium concentration and prostate cancer risk: results from the European Prospective Investigation into Cancer and Nutrition (EPIC)4.780Citations (PDF)
429Dietary fat intake and risk of prostate cancer in the European Prospective Investigation into Cancer and Nutrition4.7107Citations (PDF)
430Relevance of Positive Patch-Test Reactions to Fragrance Mix
Dermatitis, 2008, 19, 43-47
1.422Citations (PDF)
431Incidence of cancer in first-degree relatives of basal cell carcinoma patients1.63Citations (PDF)
432Genome-wide association yields new sequence variants at seven loci that associate with measures of obesity
Nature Genetics, 2008, 41, 18-24
25.21,305Citations (PDF)
433Glenohumeral joint injection: a comparative study of ultrasound and fluoroscopically guided techniques before MR arthrography
European Radiology, 2008, 19, 722-730
3.6132Citations (PDF)
434Serum Insulin-like Growth Factor (IGF)-I and IGF-Binding Protein-3 Concentrations and Prostate Cancer Risk: Results from the European Prospective Investigation into Cancer and Nutrition1.192Citations (PDF)
435Age- and gender-specific reference values of estimated GFR in Caucasians: The Nijmegen Biomedical Study
Kidney International, 2007, 72, 632-637
5.3348Citations (PDF)
436Durability of 30-Minute High-Energy Transurethral Microwave Therapy for Treatment of Benign Prostatic Hyperplasia: A Study of 213 Patients With and Without Urinary Retention
Urology, 2007, 69, 854-858
1.419Citations (PDF)
437Testicular cancer: Trends in mortality are well explained by changes in treatment and survival in the southern Netherlands since 1970
European Journal of Cancer, 2007, 43, 2553-2558
4.925Citations (PDF)
438Coal tar in dermatology2.843Citations (PDF)
439Prognostic Value of p53 for High Risk Superficial Bladder Cancer With Long-Term Followup
Journal of Urology, 2007, 177, 80-83
4.236Citations (PDF)
440Plasma carotenoids, retinol, and tocopherols and the risk of prostate cancer in the European Prospective Investigation into Cancer and Nutrition study4.7116Citations (PDF)
441Uncommon breast tumors in perspective: Incidence, treatment and survival in the Netherlands4.3125Citations (PDF)
442Serum androgens and prostate cancer among 643 cases and 643 controls in the European Prospective Investigation into Cancer and Nutrition
International Journal of Cancer, 2007, 121, 1331-1338
4.386Citations (PDF)
443Ultrasound-Guided Transrectal Implantation of Gold Markers for Prostate Localization During External Beam Radiotherapy: Complication Rate and Risk Factors1.562Citations (PDF)
444Clinical efficacy of a new 30-min algorithm for transurethral microwave thermotherapy: initial results
BJU International, 2007, 86, 47-51
3.27Citations (PDF)
445The prognostic value of E‐cadherin and the cadherin‐associated molecules α‐, β‐, γ‐catenin and p120ctn in prostate cancer specific survival: A long‐term follow‐up study
Prostate, 2007, 67, 1432-1438
2.155Citations (PDF)
446Genetic determinants of hair, eye and skin pigmentation in Europeans
Nature Genetics, 2007, 39, 1443-1452
25.2711Citations (PDF)
447Genome-wide association study identifies a second prostate cancer susceptibility variant at 8q24
Nature Genetics, 2007, 39, 631-637
25.2831Citations (PDF)
448Two variants on chromosome 17 confer prostate cancer risk, and the one in TCF2 protects against type 2 diabetes
Nature Genetics, 2007, 39, 977-983
25.2682Citations (PDF)
449Common variants on chromosomes 2q35 and 16q12 confer susceptibility to estrogen receptor–positive breast cancer
Nature Genetics, 2007, 39, 865-869
25.2780Citations (PDF)
450The impact of lower urinary tract symptoms and comorbidities on quality of life: the BACH and UREPIK studies
BJU International, 2007, 99, 347-354
3.2149Citations (PDF)
451Gene Expression Analysis for the Prediction of Recurrence in Patients with Primary Ta Urothelial Cell Carcinoma
European Urology, 2007, 51, 416-423
2.125Citations (PDF)
452Human Papilloma Virus DNA and p53 Mutation Analysis on Bladder Washes in Relation to Clinical Outcome of Bladder Cancer
European Urology, 2007, 52, 464-469
2.140Citations (PDF)
453Carotenoid and vitamin intake, von Hippel-Lindau gene mutations and sporadic renal cell carcinoma
Cancer Causes and Control, 2007, 19, 125-134
1.725Citations (PDF)
454Polymorphisms in genes related to activation or detoxification of carcinogens might interact with smoking to increase renal cancer risk: results from The Netherlands Cohort Study on diet and cancer
World Journal of Urology, 2007, 26, 103-110
2.211Citations (PDF)
455Post-Void Residual Urine Volume is Not a Good Predictor of the Need for Invasive Therapy Among Patients With Benign Prostatic Hyperplasia
Journal of Urology, 2006, 175, 213-216
4.235Citations (PDF)
456Cardiovascular Risk Among Men Seeking Help for Erectile Dysfunction
Annals of Epidemiology, 2006, 16, 85-90
1.737Citations (PDF)
457Segregation analysis of urothelial cell carcinoma
European Journal of Cancer, 2006, 42, 1428-1433
4.932Citations (PDF)
458Numerous high-risk epithelial lesions in familial breast cancer
European Journal of Cancer, 2006, 42, 2492-2498
4.927Citations (PDF)
459Polymorphisms in the E-cadherin (CDH1) gene promoter and the risk of bladder cancer
European Journal of Cancer, 2006, 42, 3219-3227
4.924Citations (PDF)
460Accurate prediction of need for invasive treatment in alpha1-blocker treated patients with benign prostatic hyperplasia not possible: Bootstrap validation analysis
Urology, 2006, 67, 984-989
1.42Citations (PDF)
461PSA velocity in conservatively managed BPH: Can it predict the need for BPH-related invasive therapy?
Prostate, 2006, 66, 1407-1412
2.16Citations (PDF)
462Correlation between quality of life and voiding variables in patients treated with percutaneous tibial nerve stimulation
BJU International, 2006, 97, 113-116
3.230Citations (PDF)
463Polymorphisms in the alpha1A-adrenoceptor gene do not modify the short- and long-term efficacy of alpha1-adrenoceptor antagonists in the treatment of benign prostatic hyperplasia
BJU International, 2006, 97, 852-855
3.213Citations (PDF)
464Cigarette smoking, von Hippel–Lindau gene mutations and sporadic renal cell carcinoma
British Journal of Cancer, 2006, 95, 374-377
5.522Citations (PDF)
465A comparison of the diagnostic performance of systematic versus ultrasound-guided biopsies of prostate cancer
European Radiology, 2006, 16, 927-938
3.697Citations (PDF)
466Current Practice in the Management of Superficial Bladder Cancer in the Netherlands and Belgian Flanders: A Survey
European Urology, 2006, 49, 478-484
2.122Citations (PDF)
467The Predictive Value of p53, p27Kip1, and α-Catenin for Progression in Superficial Bladder Carcinoma
European Urology, 2006, 50, 76-82
2.122Citations (PDF)
468Quantitative Cytology on Bladder Wash versus Voided Urine: A Comparison of Results
European Urology, 2006, 49, 1044-1050
2.15Citations (PDF)
469Prediction of recurrence in Ta urothelial cell carcinoma by real-time quantitative PCR analysis: A microarray validation study
International Journal of Cancer, 2006, 119, 1915-1919
4.318Citations (PDF)
470Tobacco smoke and bladder cancer-in the European prospective investigation into cancer and nutrition
International Journal of Cancer, 2006, 119, 2412-2416
4.367Citations (PDF)
471Hypospadias: a transgenerational effect of diethylstilbestrol?
Human Reproduction, 2006, 21, 666-669
1.0144Citations (PDF)
472Sperm integrity pre- and post-chemotherapy in men with testicular germ cell cancer
Human Reproduction, 2006, 21, 1781-1786
1.0108Citations (PDF)
473Survivin and MKI67 mRNA Expression in Bladder Washings of Patients with Superficial Urothelial Cell Carcinoma Correlate with Tumor Stage and Grade but Do Not Predict Tumor Recurrence
Clinical Chemistry, 2006, 52, 1440-1442
1.15Citations (PDF)
474Thyroid Function and Prevalence of Anti-Thyroperoxidase Antibodies in a Population with Borderline Sufficient Iodine Intake: Influences of Age and Sex
Clinical Chemistry, 2006, 52, 104-111
1.1215Citations (PDF)
475Risk factors for hypospadias
European Journal of Pediatrics, 2006, 166, 671-678
2.1130Citations (PDF)
476Post-Void Residual Urine Volume is Not a Good Predictor of the Need for Invasive Therapy Among Patients With Benign Prostatic Hyperplasia
Journal of Urology, 2006, 175, 213???216
4.20Citations (PDF)
477Hypertension, antihypertensives and mutations in the Von Hippel–Lindau gene in renal cell carcinoma: results from the Netherlands Cohort Study
Journal of Hypertension, 2005, 23, 1997-2004
2.131Citations (PDF)
478Prognostic factors for a subsequent basal cell carcinoma: implications for follow-up
British Journal of Dermatology, 2005, 153, 1078-1080
1.730Citations (PDF)
479The Efficacy of Different Follow-Up Strategies in Clinical Stage I Non-Seminomatous Germ Cell Cancer: A Markov Simulation Study
European Urology, 2005, 48, 258-268
2.18Citations (PDF)
480Does the Tertiary Gleason Pattern Influence the PSA Progression-Free Interval after Retropubic Radical Prostatectomy for Organ-Confined Prostate Cancer?
European Urology, 2005, 48, 572-576
2.149Citations (PDF)
481Urinary NMP22® BladderChek® Test in the Diagnosis of Superficial Bladder Cancer
European Urology, 2005, 48, 951-956
2.163Citations (PDF)
482Long‐Term Effect of Inhibition of the Angiotensin‐Converting Enzyme (ACE) on Cavernosal Perfusion in Men with Atherosclerotic Erectile Dysfunction: A Pilot Study
Journal of Sexual Medicine, 2005, 2, 207-212
0.531Citations (PDF)
483Alcohol consumption and risk of prostate cancer in middle-aged men4.3109Citations (PDF)
484CDC91L1 (PIG-U) mRNA expression in urothelial cell carcinomas4.39Citations (PDF)
485Vegetable and fruit consumption and risk of renal cell carcinoma: Results from the Netherlands cohort study4.350Citations (PDF)
486Prognostic role of prostate-specific antigen and prostate volume for the risk of invasive therapy in patients with benign prostatic hyperplasia initially managed with alpha1-blockers and watchful waiting
Urology, 2005, 65, 300-305
1.427Citations (PDF)
487Bladder cancer: Epidemiology, staging and grading, and diagnosis
Urology, 2005, 66, 4-34
1.4954Citations (PDF)
488Relation of Height, Body Mass, Energy Intake, and Physical Activity to Risk of Renal Cell Carcinoma: Results from the Netherlands Cohort Study
American Journal of Epidemiology, 2004, 160, 1159-1167
3.393Citations (PDF)
489Survivin mRNA Copy Number in Bladder Washings Predicts Tumor Recurrence in Patients with Superficial Urothelial Cell Carcinomas
Clinical Chemistry, 2004, 50, 1425-1428
1.143Citations (PDF)
490The prevalence of urinary incontinence in community-dwelling married women: a matter of definition
BJU International, 2004, 94, 1291-1295
3.244Citations (PDF)
491CDC91L1 (PIG-U) is a newly discovered oncogene in human bladder cancer
Nature Medicine, 2004, 10, 374-381
33.090Citations (PDF)
492Prognosis of Muscle-Invasive Bladder Cancer: Difference between Primary and Progressive Tumours and Implications for Therapy
European Urology, 2004, 45, 292-296
2.1260Citations (PDF)
493Preliminary European Results of Local Microwave Hyperthermia and Chemotherapy Treatment in Intermediate or High Risk Superficial Transitional Cell Carcinoma of the Bladder
European Urology, 2004, 46, 65-72
2.1147Citations (PDF)
494Efficacy of routine follow-up after first-line treatment for testicular cancer
World Journal of Urology, 2004, 22, 235-243
2.28Citations (PDF)
495Fruits and vegetables and prostate cancer: No association among 1,104 cases in a prospective study of 130,544 men in the European Prospective Investigation into Cancer and Nutrition (EPIC)4.3100Citations (PDF)
496Site-specific familial aggregation of prostate cancer4.325Citations (PDF)
497Posterior tibial nerve stimulation in the treatment of voiding dysfunction: Urodynamic data
Neurourology and Urodynamics, 2004, 23, 246-251
1.764Citations (PDF)
498Association of metabolic gene polymorphisms with alcohol consumption in controls
Biomarkers, 2004, 9, 180-189
1.95Citations (PDF)
499Lower urinary tract symptoms after renal transplantation: are there changes over time?
Urology, 2004, 63, 442-446
1.420Citations (PDF)
500Routine bladder biopsies in men with bladder outlet obstruction?
Urology, 2004, 63, 451-456
1.48Citations (PDF)
501Phenotypic Characteristics of Male Subfertility and Its Familial Occurrence
Journal of Andrology, 2004, 25, 819-823
2.121Citations (PDF)
502How Strong Is the Association Between CAG and GGN Repeat Length Polymorphisms in the Androgen Receptor Gene and Prostate Cancer Risk?1.1106Citations (PDF)
503Review: Inherited predisposition to prostate cancer5.320Citations (PDF)
504Title is missing!
Familial Cancer, 2003, 2, 57-67
1.423Citations (PDF)
505Title is missing!
Familial Cancer, 2003, 2, 101-108
1.411Citations (PDF)
506DD3PCA3-based Molecular Urine Analysis for the Diagnosis of Prostate Cancer
European Urology, 2003, 44, 8-16
2.1651Citations (PDF)
507Prostate-Specific Antigen as an Estimator of Prostate Volume in the Management of Patients with Symptomatic Benign Prostatic Hyperplasia
European Urology, 2003, 44, 695-700
2.185Citations (PDF)
508Female carriers of fragile X premutations have no increased risk for additional diseases other than premature ovarian failure0.551Citations (PDF)
509Posterior tibial nerve stimulation in the treatment of urge incontinence1.7142Citations (PDF)
510Percutaneous tibial nerve stimulation in the treatment of overactive bladder: Urodynamic data
Neurourology and Urodynamics, 2003, 22, 227-232
1.7107Citations (PDF)
511Very low incidence of microsatellite instability in rectal cancers from families at risk for HNPCC
Clinical Genetics, 2003, 63, 64-70
2.120Citations (PDF)
512The prevalence of lower urinary tract symptoms in men and women in four centres. The UrEpik study
BJU International, 2003, 92, 409-414
3.2267Citations (PDF)
513The relationship between lower urinary tract symptoms and health status: the UREPIK study
BJU International, 2003, 92, 575-580
3.256Citations (PDF)
514The association between lower urinary tract symptoms and erectile dysfunction in four centres: the UrEpik study
BJU International, 2003, 92, 719-725
3.2133Citations (PDF)
515Transurethral resection vs microwave thermotherapy of the prostate: a cost‐consequences analysis
BJU International, 2003, 92, 713-718
3.252Citations (PDF)
516The impact of intensive antileukaemic treatment strategies on prognosis of myelodysplastic syndrome patients aged less than 61 years according to International Prognostic Scoring System risk groups2.719Citations (PDF)
517Allelic imbalance in hereditary and sporadic prostate cancer
Prostate, 2003, 54, 50-57
2.113Citations (PDF)
518The prevalence of male urinary incontinence in four centres: the UREPIK study
BJU International, 2003, 92, 943-947
3.268Citations (PDF)
519Fertility in men with testicular germ cell tumors
Fertility and Sterility, 2003, 79, 1543-1549
2.976Citations (PDF)
520Rational and experimental basis for DD3PCA3 molecular urine analysis to specific diagnosis of prostate cancer0.10Citations (PDF)
521Underestimation of Subfertility Among Relatives When Using a Family History: Taboo Bias
Journal of Andrology, 2003, 24, 285-288
2.17Citations (PDF)
522Urodynamic effects of alpha-adrenoceptor blockers: a review of clinical trials
Urology, 2003, 62, 1-9
1.459Citations (PDF)
523Posterior tibial nerve stimulation in the treatment of idiopathic nonobstructive voiding dysfunction
Urology, 2003, 61, 567-572
1.444Citations (PDF)
524High Prevalence of Premalignant Lesions in Prophylactically Removed Breasts From Women at Hereditary Risk for Breast Cancer16.9146Citations (PDF)
525Activated Leukocyte Cell Adhesion Molecule (ALCAM) Expression is Associated with a Poor Prognosis for Bladder Cancer Patients
UroOncology, 2003, 3, 121-129
0.121Citations (PDF)
526Drug survival, efficacy and toxicity of monotherapy with a fully human anti-tumour necrosis factor-alpha antibody compared with methotrexate in long-standing rheumatoid arthritis2.154Citations (PDF)
527A method for estimating within-patient variability in maximal urinary flow rate adjusted for voided volume
Urology, 2002, 59, 368-372
1.414Citations (PDF)
528Difference in stage and morphology-adjusted survival between young and elderly patients with a testicular germ cell tumor
Urology, 2002, 60, 889-893
1.438Citations (PDF)
529Long-Term Risk Of Re-Treatment Of Patients Using α-Blockers For Lower Urinary Tract Symptoms
Journal of Urology, 2002, 167, 1734-1739
4.297Citations (PDF)
530Baseline Prostatic Specific Antigen Does Not Predict The Outcome Of High Energy Transurethral Microwave Thermotherapy
Journal of Urology, 2002, 167, 1727-1730
4.214Citations (PDF)
531IS INCREASED CAG REPEAT LENGTH IN THE ANDROGEN RECEPTOR GENE A RISK FACTOR FOR MALE SUBFERTILITY?
Journal of Urology, 2002, 167, 621-623
4.243Citations (PDF)
532Familial aggregation of urothelial cell carcinoma4.3110Citations (PDF)
533Single‐nucleotide polymorphism in the E‐cadherin gene promoter modifies the risk of prostate cancer4.358Citations (PDF)
534Segregation analysis of 389 Icelandic pedigrees with Breast and prostate cancer
Genetic Epidemiology, 2002, 23, 349-363
3.111Citations (PDF)
535The natural history of chronic urticaria and angioedema in patients visiting a tertiary referral centre
British Journal of Dermatology, 2002, 146, 110-113
1.7144Citations (PDF)
536The role of 18 fluoro‐2‐deoxyglucose positron emission tomography in initial staging and re‐staging after chemotherapy for testicular germ cell tumours
BJU International, 2002, 89, 549-556
3.2141Citations (PDF)
537IS INCREASED CAG REPEAT LENGTH IN THE ANDROGEN RECEPTOR GENE A RISK FACTOR FOR MALE SUBFERTILITY?
Journal of Urology, 2002, , 621-623
4.211Citations (PDF)
538Baseline Prostatic Specific Antigen Does Not Predict The Outcome Of High Energy Transurethral Microwave Thermotherapy
Journal of Urology, 2002, , 1727-1730
4.22Citations (PDF)
539Long-Term Risk Of Re-Treatment Of Patients Using ??-Blockers For Lower Urinary Tract Symptoms
Journal of Urology, 2002, , 1734-1739
4.229Citations (PDF)
540POSTERIOR TIBIAL NERVE STIMULATION AS NEUROMODULATIVE TREATMENT OF LOWER URINARY TRACT DYSFUNCTION
Journal of Urology, 2001, 166, 914-918
4.2198Citations (PDF)
541Autosomal dominant inheritance of prostate cancer: a confirmatory study
Urology, 2001, 57, 97-101
1.448Citations (PDF)
542Absence of karyotype abnormalities in patients with familial urothelial cell carcinoma
Urology, 2001, 57, 266-269
1.46Citations (PDF)
543Cancer incidence in relatives of patients with testicular cancer in the eastern part of The Netherlands
Urology, 2001, 57, 747-752
1.428Citations (PDF)
544Diagnostic efficacy of the Immunocyt test to detect superficial bladder cancer recurrence
Urology, 2001, 58, 367-371
1.482Citations (PDF)
545LONG-TERM FOLLOWUP OF RANDOMIZED TRANSURETHRAL MICROWAVE THERMOTHERAPY VERSUS TRANSURETHRAL PROSTATIC RESECTION STUDY
Journal of Urology, 2001, 165, 1533-1538
4.299Citations (PDF)
546α-BLOCKADE IMPROVES SYMPTOMS SUGGESTIVE OF BLADDER OUTLET OBSTRUCTION BUT FAILS TO RELIEVE IT
Journal of Urology, 2001, 165, 38-41
4.259Citations (PDF)
547Routine follow-up examinations in breast cancer patients have minimal impact on life expectancy: A simulation study
Annals of Oncology, 2001, 12, 1107-1113
9.934Citations (PDF)
548Superficial and metachronous invasive bladder carcinomas are clonally related4.324Citations (PDF)
549The relationship between disease activity, joint destruction, and functional capacity over the course of rheumatoid arthritis
Arthritis and Rheumatism, 2001, 44, 2009-2017
6.1440Citations (PDF)
550Social epidemiology? No way4.946Citations (PDF)
551Increased serum FSH in female fragile X premutation carriers with either regular menstrual cycles or on oral contraceptives
Human Reproduction, 2001, 16, 457-462
1.084Citations (PDF)
552Response4.90Citations (PDF)
553LONG-TERM FOLLOWUP OF RANDOMIZED TRANSURETHRAL MICROWAVE THERMOTHERAPY VERSUS TRANSURETHRAL PROSTATIC RESECTION STUDY
Journal of Urology, 2001, , 1533-1538
4.24Citations (PDF)
554POSTERIOR TIBIAL NERVE STIMULATION AS NEUROMODULATIVE TREATMENT OF LOWER URINARY TRACT DYSFUNCTION
Journal of Urology, 2001, , 914-918
4.260Citations (PDF)
555Genetic epidemiology of breast cancer: Segregation analysis of 389 Icelandic pedigrees
2000, 18, 81-94
10Citations (PDF)
556Cancer in the very elderly Dutch population
Cancer, 2000, 89, 1121-1133
4.074Citations (PDF)
557Mutagen sensitivity in patients with familial and non-familial urothelial cell carcinoma4.35Citations (PDF)
558Variability of pressure-flow studies in men with lower urinary tract symptoms
Neurourology and Urodynamics, 2000, 19, 637-656
1.736Citations (PDF)
559Imprinting Effect in Premature Ovarian Failure Confined to Paternally Inherited Fragile X Premutations6.5132Citations (PDF)
560Lower incidence of urothelial cell carcinoma due to the concept of a clonal origin
European Journal of Cancer, 2000, 36, 2385-2389
4.97Citations (PDF)
561Gender differences in stage-adjusted bladder cancer survival
Urology, 2000, 55, 876-880
1.4213Citations (PDF)
562Long-term follow-up of laser treatment for lower urinary tract symptoms suggestive of bladder outlet obstruction
Urology, 2000, 56, 604-609
1.421Citations (PDF)
563Patient opinion of urinary tests versus flexible urethrocystoscopy in follow-up examination for superficial bladder cancer: a utility analysis
Urology, 2000, 56, 793-797
1.477Citations (PDF)
564Urinary bladder cancer test: a new urinary tumor marker in the follow-up of superficial bladder cancer
Urology, 2000, 56, 787-791
1.441Citations (PDF)
565Gender differences in stage distribution of bladder cancer
Urology, 2000, 55, 368-371
1.4136Citations (PDF)
566HIGH ENERGY TRANSURETHRAL MICROWAVE THERMOTHERAPY FOR THE TREATMENT OF PATIENTS IN URINARY RETENTION
Journal of Urology, 2000, 163, 1457-1460
4.228Citations (PDF)
567PREDICTION OF BLADDER OUTLET OBSTRUCTION IN MEN WITH LOWER URINARY TRACT SYMPTOMS USING ARTIFICIAL NEURAL NETWORKS
Journal of Urology, 2000, 163, 300-305
4.239Citations (PDF)
568PREDICTION OF BLADDER OUTLET OBSTRUCTION IN MEN WITH LOWER URINARY TRACT SYMPTOMS USING ARTIFICIAL NEURAL NETWORKS
Journal of Urology, 2000, , 300
4.20Citations (PDF)
569HIGH ENERGY TRANSURETHRAL MICROWAVE THERMOTHERAPY FOR THE TREATMENT OF PATIENTS IN URINARY RETENTION
Journal of Urology, 2000, , 1457-1460
4.21Citations (PDF)
570Renal Cell Cancer: Chromosome 3 Translocations as Risk Factors4.658Citations (PDF)
571Increased risk of fatal prostate cancer may explain the rise in mortality in The Netherlands4.917Citations (PDF)
572Can histopathology predict treatment outcome following high-energy transurethral microwave thermotherapy of the prostate? Results of a biopsy study
1999, 40, 28-36
26Citations (PDF)
573Low reproducibility of maximum urinary flow rate determined by portable flowmetry
Neurourology and Urodynamics, 1999, 18, 183-191
1.731Citations (PDF)
574Results of high-energy transurethral microwave thermotherapy in patients categorized according to the american society of anesthesiologists operative risk classification
Urology, 1999, 53, 322-328
1.427Citations (PDF)
575INTERNATIONAL POPULATION-BASED STUDY OF UROLOGICAL CONDITIONS
Journal of Urology, 1999, , 32
4.25Citations (PDF)
576Diagnostic research in benign prostatic hyperplasia - from sensitivity to neural networks2.04Citations (PDF)
577PREDICTION OF BLADDER OUTLET OBSTRUCTION USING A BACKPROPAGATION NEURAL NETWORK
Journal of Urology, 1999, , 289
4.20Citations (PDF)
578A Common Genetic Mechanism Determines Plasma Apolipoprotein B Levels and Dense LDL Subfraction Distribution in Familial Combined Hyperlipidemia6.523Citations (PDF)
579URINARY TRACT CANCER AND HEREDITARY NONPOLYPOSIS COLORECTAL CANCER: RISKS AND SCREENING OPTIONS
Journal of Urology, 1998, 160, 466-470
4.2119Citations (PDF)
580Impact of urometabolic evaluation on prevention of urolithiasis: a retrospective study
Urology, 1998, 52, 384-391
1.429Citations (PDF)
581Microstaging of pT1 transitional cell carcinoma of the bladder: identification of subgroups with distinct risks of progression
Urology, 1998, 52, 1009-1013
1.4117Citations (PDF)
582LONG-TERM RESULTS OF LOWER ENERGY TRANSURETHRAL MICROWAVE THERMOTHERAPY
Journal of Urology, 1998, 159, 1966-1973
4.238Citations (PDF)
583LONG-TERM RESULTS OF LOWER ENERGY TRANSURETHRAL MICROWAVE THERMOTHERAPY
Journal of Urology, 1998, , 1966-1972
4.21Citations (PDF)
584URINARY TRACT CANCER AND HEREDITARY NONPOLYPOSIS COLORECTAL CANCER
Journal of Urology, 1998, , 466-470
4.24Citations (PDF)
585LONG-TERM RESULTS OF LOWER ENERGY TRANSURETHRAL MICROWAVE THERMOTHERAPY
Journal of Urology, 1998, , 1973
4.20Citations (PDF)
586Familial Transitional Cell Carcinoma Among the Population of Iceland
Journal of Urology, 1997, 157, 1649-1651
4.232Citations (PDF)
587QUALITY OF LIFE ASSESSMENT IN PATIENTS TREATED WITH LOWER ENERGY THERMOTHERAPY (PROSTASOFT 2.0): RESULTS OF A RANDOMIZED TRANSURETHRAL MICROWAVE THERMOTHERAPY VERSUS SHAM STUDY
Journal of Urology, 1997, 158, 1839-1844
4.233Citations (PDF)
588Remarkable age-dependent sex differences in the incidence of adenocarcinoma of the gastric cardia and oesophagus in The Netherlands4.97Citations (PDF)
589Family studies and the evidence for genetic susceptibility to prostate cancer13.711Citations (PDF)
590Serum CA 125 concentrations in women of different ages, hormonal statuses, orclinical conditions2.74Citations (PDF)
591Prognostic value of serial CA125 measurements during chemotherapy for patients with advanced ovarian cancer2.73Citations (PDF)
592Quality-of-life assessment in patients after laser prostatectomy
BJU International, 1997, 80, 211-216
3.210Citations (PDF)
593Segregation Analysis of Plasma Apolipoprotein B Levels in Familial Combined Hyperlipidemia6.036Citations (PDF)
594Familial Transitional Cell Carcinoma Among the Population of Iceland
Journal of Urology, 1997, , 1649-1651
4.20Citations (PDF)
595Reliability of the International Prostate Symptom Score in the Assessment of Patients With Lower Urinary Tract Symptoms and/or Benign Prostatic Hyperplasia
Journal of Urology, 1996, 155, 1959-1964
4.242Citations (PDF)
596The Correlation Between Bladder Outlet Obstruction and Lower Urinary Tract Symptoms as Measured by the International Prostate Symptom Score
Journal of Urology, 1996, 156, 1020-1025
4.271Citations (PDF)
597Familial Transitional Cell Carcinoma
Journal of Urology, 1996, 156, 867-872
4.256Citations (PDF)
598Correlation between uroflowmetry, prostate volume, postvoid residue, and lower urinary tract symptoms as measured by the international prostate symptom score
Urology, 1996, 48, 393-397
1.4113Citations (PDF)
599Ovarian cancer incidence (1989–1991) and mortality (1954–1993) in the Netherlands
Obstetrics and Gynecology, 1996, 88, 387-393
1.925Citations (PDF)
600Decreasing bladder cancer mortality in the Netherlands
BJU International, 1996, 78, 686-690
3.24Citations (PDF)
601Urban-Rural Differences in Cancer Incidence in The Netherlands, 1989–19914.966Citations (PDF)
602Reliability of the International Prostate Symptom Score in the Assessment of Patients With Lower Urinary Tract Symptoms and/or Benign Prostatic Hyperplasia
Journal of Urology, 1996, , 1959-1964
4.29Citations (PDF)
603Germline Translocation t(5;20)(p15;q11) and Familial Transitional Cell Carcinoma
Journal of Urology, 1996, , 1035-1036
4.20Citations (PDF)
604The Correlation Between Bladder Outlet Obstruction and Lower Urinary Tract Symptoms as Measured by the International Prostate Symptom Score
Journal of Urology, 1996, , 1020-1025
4.213Citations (PDF)
605Familial Transitional Cell Carcinoma
Journal of Urology, 1996, , 867-872
4.20Citations (PDF)
606Two-locus approach of segregation and linkage analysis in the study of complex traits
Genetic Epidemiology, 1995, 12, 825-830
3.12Citations (PDF)
607Risk of Cancer in Relatives of Prostate Cancer Probands4.6135Citations (PDF)
608False-negative findings in skin cancer and melanoma screening1.865Citations (PDF)
609Frequency of familial melanoma and MLM2 gene
Lancet, The, 1995, 345, 581-582
62.12Citations (PDF)
610Ascertainment Corrected Rates4.910Citations (PDF)
611The Capture-Recapture Method for Estimation of Cancer Registry Completeness: A Useful Tool?4.986Citations (PDF)
612Cancer incidence: life table risk versus cumulative risk.2.957Citations (PDF)
613Mortality trend from prostate cancer in the Netherlands (1950-1989)
Prostate, 1994, 24, 33-38
2.120Citations (PDF)
614Should random urothelial biopsies be taken from patients with primary superficial bladder cancer? A decision analysis
British Journal of Urology, 1994, 73, 164-171
0.1104Citations (PDF)
615The influence of review pathology on study outcome of a randomized multicentre superficial bladder cancer trial
British Journal of Urology, 1994, 73, 172-176
0.170Citations (PDF)
616Bladder cancer incidence and survival in the south-eastern part of the Netherlands, 1975–1989
European Journal of Cancer, 1994, 30, 1134-1137
4.942Citations (PDF)
617Risk of endometrial cancer after tamoxifen treatment of breast cancer
Lancet, The, 1994, 343, 448-452
62.1568Citations (PDF)
618Dysplasia in normal-looking urothelium increases the risk of tumour progression in primary superficial bladder cancer
European Journal of Cancer, 1994, 30, 1621-1625
4.964Citations (PDF)
619Prognostic assessment from studies with non-randomized treatment assignment3.76Citations (PDF)
620Swimming and the risk of cutaneous melanoma
Melanoma Research, 1994, 4, 281-286
1.562Citations (PDF)
621The clinical epidemiology of superficial bladder cancer
British Journal of Cancer, 1993, 67, 806-812
5.5130Citations (PDF)
622Bladder Cancer Mortality in the Netherlands, 1955–19880.10Citations (PDF)
623Lack of selective attendance of participants at skin cancer/melanoma screening clinics1.820Citations (PDF)
624Trends in mortality from malignant cutaneous melanoma in The Netherlands, 1950–1988
European Journal of Cancer, 1993, 29, 107-111
4.926Citations (PDF)
625Melanoma and occupation: results of a case-control study in The Netherlands.2.89Citations (PDF)
626A plea for better coding rules for bladder cancer
British Journal of Cancer, 1993, 68, 1254-1255
5.50Citations (PDF)
627Predictability of Recurrent and Progressive Disease in Individual Patients with Primary Superficial Bladder Cancer
Journal of Urology, 1993, 150, 60-64
4.2196Citations (PDF)
628Effect of intermittent exposure to sunlight on melanoma risk among indoor workers and sun-sensitive individuals.8.383Citations (PDF)
629Effect of Intermittent Exposure to Sunlight on Melanoma Risk among Indoor Workers and Sun-Sensitive Individuals8.37Citations (PDF)
630Random bladder biopsies and the risk of recurrent superficial bladder cancer: a prospective study in 1026 patients2.229Citations (PDF)
631Fundamentals of skin cancer/melanoma screening campaigns1.118Citations (PDF)
632Bladder Cancer Mortality in the Netherlands, 1955–19880.13Citations (PDF)
633Melanoma/skin cancer screening clinics: Experiences in the Netherlands1.842Citations (PDF)
634Information Bias in a CaseʼReferent Study on Mental Retardation and Parental Occupation
Epidemiology, 1990, 1, 292-297
2.818Citations (PDF)
635Title is missing!
0
2Citations (PDF)
636The impact of treatment for muscle‐invasive bladder cancer on health‐related quality of life
BJU International, 0, 136, 657-668
3.22Citations (PDF)
637Physical activity and risks of recurrence and progression among patients with non‐muscle invasive bladder cancer4.30Citations (PDF)
638Recurrence Patterns in a Large Contemporary Cohort of Patients With Non-Muscle Invasive Bladder Cancer2.31Citations (PDF)
639The impact of positive surgical margins after cystectomy on oncological outcomes: a nationwide study from the Prospective Bladder Cancer Infrastructure (ProBCI)0.10Citations (PDF)
640Surveillance patterns in non‐muscle‐invasive bladder cancer across risk groups: a real‐world analysis3.20Citations (PDF)